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ABSTRACT
CONSTRUCTION OF AN ESCHERICHIA COLILAC REPRESSOR-BASED
SYSTEM TO STUDY HUMAN CYTOMEGALOVIRUS GENE EXPRESSION
Laura Fernanda Cageao-Luchetti
Eastern Virginia Medical School and Old Dominion University, 1999
Director: Dr. Richard M. Stenberg

An Escherichia coli lac repressor-based system was developed to study the roles
of human cytomegalovirus (HCMV) genes during viral replication. To this end, a
recombinant HCMV expressing the lac repressor was generated (RV/orc), and an
HCMV-specific promoter was targeted for conditional expression by inserting the lac
operator sequence. The promoter of a nonessential gene was chosen in order to be able
to assess parameters of repression and derepression of the operator-containing promoter
in the endogenous locus, without having virus growth dependent on the specific inducer
isopropylthiogalactoside (IPTG). The feasibility of this approach to conditionally
express an HCMV promoter was demonstrated by analyzing lac operator-containing,
HCMV US9 promoters in CAT reporter constructs, using RVlac and IPTG in transient
assays. This study demonstrates that efficient repression mediated by the lac repressor
can be achieved, and this repression is efficiently reversed by IPTG. In addition, the
operator-containing US9 promoters were inserted into the endogenous locus to
investigate the impact of the operator insertion on basal promoter expression in the
context of the virus, before these constructs are used to study conditional expression in
the viral genome. It was observed that US9 endogenous promoter expression was not
affected significantly by the operator insertions. Because attempts to isolate a
recombinant virus containing the operator-containing US9 promoter and expressing the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

lac repressor were unsuccessful, future studies should target the insertion of the
operator-containing US9 promoter and the lac repressor gene into two separate
recombinant viruses. These viruses could be used in coinfection experiments to address
conditional US9 gene expression. Furthermore, alternative sites for insertion of the
operator sequence within the US9 promoter should also be evaluated. After
demonstrating the feasibility of this approach in the context of the viral genome, the
system can then be adapted to target putative essential HCMV genes.
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CHAPTER I
INTRODUCTION
Cytomegaloviruses: classification and general characteristics
Cytomegaloviruses (CMV) are animal DNA viruses that are widely distributed in
nature. These viruses belong to the Herpesviridae family, and were initially defined as
salivary gland viruses, due to the central role played by this organ as a target for virus
replication. Later, the name cytomegalovirus (CMV) was proposed, to reflect the virus
induced cytomegalia, a phenotype characterized by enlargement of the cell, and the
distinct cytopathology involving both nuclear and cytoplasmic inclusions in the infected
cell. This name also reflects the role of this virus in congenitally acquired cytomegalic
inclusion disease (CID) (reviewed by Mocarski, 1996).
Human Herpesvirus S (human cytomegalovirus (HCMV)) has been the most
studied cytomegalovirus, and is the prototype of the betaherpesvirinae subfamily. A
significant characteristic of this subfamily is the restricted host range of all of its
members. They all present a long replicative cycle, and infection proceeds rather slowly
in cells in culture. A typical feature of cytomegalovirus-infected cells is cytomegalia.
Like all herpesviruses, CMV persists in the infected host for life (see Viral Pathogenesis
section in this chapter) (reviewed by Roizman, 1996).
HCMV is strongly species specific. It will not replicate or cause disease in any
animal species other than humans (reviewed by Huang and Kowalik, 1993). The virus is
generally acquired early in life, usually causing only mild symptoms upon primary
infection. Between 50-80 % of the adult population is seropositive for HCMV, and a
significant number of individuals shed the virus in bodily fluids. Symptomatic disease is
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rarely observed in the immunocompetent host. On the other hand, HCMV has become
significantly important as a human pathogen in the last two decades because of its
involvement in serious morbidity and even mortality in immunocompromised patients.
Such patients include those receiving immunosuppressive post transplant therapies, as well
as acquired immunodeficiency syndrome (AIDS) patients (see Viral Pathogenesis section).

Human cytomegalovirus: discovery and isolation
Infection of permissive cells with cytomegalovirus results in cell enlargement and
the formation of intranuclear inclusions. In the early 1900s, these cytomegalic cells
presenting inclusion bodies were thought to result from protozoan or syphillitic infection.
Jesionek and Kiolemeoglou described these enlarged cells in several organs of infected
fetuses in 1904. Even earlier, Ribbert had observed these cells in kidney sections of a
stillborn infant in 1881. These cellular changes were also reported after the examination of
numerous postmortem submaxillary glands and other tissues from infants (reviewed by
Huang and Kowalik, 1993). All of this evidence led to the term “cytomegalic inclusion
disease” (CID) in early studies, when the virus had still not been identified (reviewed by
Britt and Alford, 1996).
Lipschutz was the first investigator to propose that CID was caused by a virus. In
1921, he defined the intranuclear inclusions that he observed as being similar to herpetic
lesions. The first experimental evidence that CID was caused by a virus was provided by
Cole and Kuttner in 1926. These investigators used a guinea pig model, and showed that
filtered homogenates of salivary glands bearing intranuclear inclusions were infectious for
animals with no previous signs of CID. When histopathologic studies of the salivary
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glands of infected animals were compared with the histologic changes observed in the
salivary glands of infected humans, the causative agent was proposed as “salivary gland
virus”.
HCMV was first isolated independently by Smith, and Rowe et al. in 1956, and by
Weller et al. in 1957. Rowe and coworkers isolated the currently commonly used
laboratory strain AD 169. This strain was inadvertently isolated instead of adenovirus from
the adenoidal tissue of a child who had undergone tonsil and adenoidectomies (Huang and
Kowalik, 1993). Smith and Weller independently isolated the virus from infants with
generalized CID. Weller et al. first used the term “cytomegalovirus” to reflect the
cytopathology produced by these viruses. Following the isolation of HCMV in the late
1950s, serological studies showed that HCMV causes a common, usually subclinical
infection that occurs worldwide. The incidence of HCMV infection is more pronounced in
the very young and old, as well as in immunocompromised individuals. Electron
microscopic work on the morphology of the virus, as well as the finding that its large
genome was composed of DNA, led to the classification of CMV as a member of the
Herpesviridae family (reviewed by Britt and Alford, 1996).

Structure of the virion
CMV virions present the typical structure of the herpesvirions. The architecture of
the virion consists of a core, a capsid, a tegument (also referred to as matrix), and an
envelope. The core contains the viral genome (see section below). This is a linear, double
stranded DNA molecule in the form of a torus. The capsid presents icosadeltahedral
symmetry, with a diameter of 100 -110 nm. It is constituted by the major (150 kilodalton

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4

(kD)) and minor (40 kD) capsid proteins. These proteins are analogous to the
predominant Herpes Simplex Virus 1 (HSV-l) capsid proteins (Gibson, 1981). The
tegument, an amorphous material surrounding the capsid, consists of twenty different
proteins, most of which are phosphorylated. This proteinacious structure is believed to be
responsible for the anchorage of the envelope to the capsid. Some of the most studied
tegument phosphoproteins are pp65 (the most abundant virion protein), pplSO, pp71,
pp28, and pp64. However, the roles of the tegument proteins, with the exception of the
virion transactivator pp71, remain undefined. The virion envelope is derived from the
infected cell plasma membrane and contains at least eight viral glycoproteins in the form of
spikes, present in four complexes (Pereira et al., 1992). Half of these HCMV
glycoproteins, gB, gH, gL, and gM, are homologous to four essential HSV-l
glycoproteins. gB is the major HCMV glycoprotein, and is a predominant target for
neutralizing antibodies (Britt et al., 1990). Neutralizing antibodies are also directed to
other viral glycoproteins (Pachl et al., 1989), like gH. The viral glycoproteins are involved
in virus attachment, penetration and entry into the host cell, as well as in cell-to-cell spread
(reviewed by Roizman, 1996).
Virions in the Herpesviridae family are pleomorphic; the sizes range from 120 to
300 nm in diameter. This variation is due to differences in the amount of tegument, or to
the state of the envelope. Like all herpesviruses, cytomegaloviruses are sensitive to low
pH, lipid solvents, and heat (reviewed by Mocarski, 1996).
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The viral genome
The herpesvirus DNAs are linear and double-stranded. They vary in molecular
weight (120 to 230 kilobase pairs (kbp)) and base composition (31 to 75 G + C mole %).
One important characteristic of these viral DNAs is their sequence arrangement. Many
herpesvirus DNAs contain repeated sequences both internally and at the termini. This
feature allows for the classification of the herpesviruses into six different groups (A, B, C,
D, E, and F), based on the six different classes of genomes of the herpesviruses (reviewed
by Roizman, 1996).
Cytomegaloviruses have the largest genomes of any of the herpesviruses (180 to
230 -240 kbp) and of any known animal viruses. HCMV DNA is approximately 50 %
larger than HSV DNA (reviewed by Gibson, 1993). In addition, the HCMV genome
contains a greater density of repeated sequences than that of any other herpesvirus.
Particularly, highly repeated regions include the DNA replication origin, orilyt, and two
transcriptional enhancers. Like HSV, HCMV presents a complex arrangement of unique
and inverted repeats that leads to the existence of four genome isomers (genome
arrangement of group E). The genome presents a unique long component (UL) and a
unique short component (US). Each component is flanked by repeated sequences in an
inverted orientation located at the genomic termini and the UL-US junction. Both the UL
and US genome components can invert relative to each other to generate four isomeric
forms (reviewed by Mocarski, 1996). HCMV virions consist o f equimolar concentrations
of these four genomic isomers.
The genome o f the HCMV AD169 strain has been completely sequenced
(European Molecular Biology Laboratory Sequence Database accession number X17403).
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It contains 208 predicted open reading frames (ORFs) (Chee et al., 1990), many of which
present high degree of DNA sequence homology. These ORFs are believed to originate
from gene duplication and have been grouped into gene families. At present, little is
known about the function of many ORFs belonging to the various gene families
(Mocarski, 1996).
The overall genomic DNA sequence homology among the HCMV strains is
approximately 95 %. Restriction mapping analysis of the viral genome has shown that
clinical isolates and laboratory-adapted strains are related. However, deletion of genomic
sequences occurs after serial undiluted passage of the virus in culture. It is believed that
these deletions have led to the loss of some of the host range capabilities of the laboratorypassaged strains AD 169 and Towne, when compared to the more limited passaged, more
virulent viruses, such as Toledo. At least 19 genes present in clinical isolates are not found
in laboratory strains (Cha et al., 1996).

Viral pathogenesis
Pathogenicity
CMV pathogenicity involves a complex balance between acute and persistent
infections. The immunocompetency of the infected individual plays a major role in the
outcome of viral infection. For HCMV, it is currently unclear if the virus is present in a
chronic (with continuous production and release of low levels of infectious virus) or true
latent (with no detectable infectious virus) state in persistently infected humans.
Macrophages and endothelial cells have been proposed as major sites of HCMV
persistence (reviewed by Fish et al., 1995). In contrast, it has recently been demonstrated

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

7

that latent murine CMV (MCMV) is harbored in the spleen, the lung, and the kidney of
infected mice (Pollock and Virgin, 1995), (Kurz et al., 1997).
Generally, primary infection with HCMV occurs during early childhood. Typically,
the virus initially infects ductal epithelial cells within the salivary gland. This is a site of
persistent viral replication following primary infection. Transmission occurs via direct or
indirect person-to-person contact, by the urine of infants, and the saliva from healthy
seropositive individuals (reviewed by Mocarski, 1996). The virus is present in
oropharyngeal secretions, urine, tears, feces, semen, cervical and vaginal excretions, breast
milk, and blood.
After primary infection, cytomegaloviruses remain persistently in their hosts for life
in a quiescent state. These viruses have evolved to coexist in equilibrium with the host.
Persistence is achieved by inducing immunosuppression in the host, and by inhibiting
immune recognition (Campbell et al., 1989 and 1992), (Campbell and Slater, 1994),
(Jones et al., 1995). In humans, reactivation of the virus results in recurrent infections with
a variety of clinical manifestations in immunosuppressed individuals, such as after organ
transplantation, during pregnancy, and in numerous AIDS and cancer patients.
Studies focusing on the pathology of HCMV infection have demonstrated that
when severe disseminated disease occurs (see following section), HCMV can be found in
virtually all organs of the infected host (reviewed by Britt and Alford, 1996). The virus
replicates in the genitourinary tract and the kidneys. In AIDS patients, the gastrointestinal
tract is involved. In newborns with CID, HCMV is present in the bile duct epithelium in
the liver. Another site of HCMV replication is the respiratory tract, typically, the mucosa
o f the upper respiratory tract in immunosuppressed individuals. In the lungs, infected cells
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are found in the alveolar and bronchial epithelium. Recently, HCMV infection of adult
AIDS patients has been shown to involve the central nervous system (CNS). CNS
involvement is also reflected in both generalized and focal structural brain damage when
severe fetal HCMV infection occurs (reviewed by Britt and Alford, 1996).
The cell types that are targets for virus replication include epithelial, endothelial
and glial cells (reviewed by Mocarski, 1996). The infected cells are typically large, the
cytoplasm becomes limited, and the nuclei are prominent. Within the nucleus, the
chromatin is marginated, and the characteristic inclusions surrounded by a clear halo are
observed. In addition to the cell types mentioned above, HCMV infects monocytes, and
this is believed to play a central role in viral pathogenesis (reviewed by Campbell, 1999),
(Michelson, 1997).
The murine model has been used extensively to address the role of
monocytes/macrophages in CMV infection. This role is dual: MCMV infected- monocytes
disseminate the virus within the infected host (Stoddart et al., 1994), and serve as
precursors of infected macrophages in the spleen, the lungs and the liver. On the other
hand, CMV- infected macrophages trigger the early, non-specific immune response to the
virus (see below). Also, as well as allowing productive viral replication, the macrophage
has been implicated in MCMV latency (Pollock et al., 1997), (Mitchell et al., 1996).
Several antiviral cytokines are produced by CMV-infected macrophages: tumor necrosis
factor alpha (TNFa), interleukins IL-8, IL-ip, IL-12, IL-6, and interferon IFNa/f)
(reviewed by Mocarski, 1996), (Orange and Biron, 1996), (Ruzek et al., 1997) (reviewed
by Campbell, 1999). Although these cytokines may control the extent of CMV replication
in the macrophage, they fail to completely eradicate the virus. Clearly, the interaction
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between CMV and the monocyte/macrophage is intricate, and multiple factors seem to
regulate the outcome of infection.
The murine model has been successfully used to study the immune responses to
CMV infections (reviewed by Campbell, 1999). In the early stages of MCMV infection,
innate non-specific immunity is responsible for controlling virus replication in acutelyinfected mice. Natural killer (NK) cells are a significant non-specific defense against CMV.
These cells are activated soon after infection, and effectively control early MCMV
infection in the target organs. In the early stages of infection, the production of IFNa/p by
the infected macrophage also represents a significant non-specific antiviral defense. This
defense is effective via direct antiviral activity, as well as the enhancement of NK cell
cytotoxicity (reviewed by Campbell, 1999). However, these innate immune responses do
not completely eliminate the virus in acutely-infected mice. Cell-mediated immunity
involving CD4 and CD8 T lymphocytes is responsible for clearing MCMV infections from
target organs. Antibodies, on the other hand, do not participate in clearing a primary
infection, but they control the extent of recurrent infections following reactivation of latent
MCMV.
In humans, cell-mediated immune responses to CMV are essential for controlling
viral infection. pp65 and pplSO tegument phosphoproteins are the principal targets of
cytotoxic T lymphocytes (CTLs) (McLaughlin et al., 1994). Other targets of CTLs are the
immediate-early protein IE72 and gB (Borysiewicz et al., 1988).
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Cytomegalovirus-associated disease
Like other herpesviruses, HCMV is ubiquitous, and the majority of the human
population tests positive for CMV infection by adulthood. In most cases, infection of a
healthy individual is clinically undetectable. Rarely, however, infection may result in a
mononucleosis syndrome clinically identical to the mononucleosis syndrome associated
with Epstein-Barr virus (EBV) infection (reviewed by Britt and Alford, 1996).
In contrast, individuals with immature or compromised immune systems may suffer
from a variety of disorders associated with HCMV infection. CMV infection is the most
common congenital viral infection in humans. In the United States, the incidence is
1-2 % per live births. The majority of these infants present subclinical infections.
Transmission in utero can result from either primary infection of, or reactivation of latent
virus in, the mother. The clinical manifestations include brain damage, mental retardation,
deafness, ocular damage, as well as hepatic disease and pneumonia. Severe cases of
disseminated disease are fatal. Less severe cases will develop central nervous system
abnormalities in the first two years of life. Infants with congenital HCMV infection excrete
large quantities of the virus persistently for years after birth. This provides a significant
reservoir for virus spread in the population (reviewed by Britt and Alford, 1996),
(reviewed by Chang and Lee, 1993).
HCMV is one of the most significant opportunistic pathogens that infects AIDS
patients. Syndromes associated with HCMV infection in AIDS patients comprise almost
every organ system. Most frequently involved are the CNS (reviewed by Wiley and
Nelson, 1993), the gastrointestinal system, and the lung. Diseases like CMV pneumonitis,
retinitis, encephalitis, esophagitis, gastritis, hepatitis, and enterocolitis are frequently
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observed (reviewed by Fiala et al., 1993), (Jacobson, 1995). Because of the poorer
prognosis of CMV-seropositive patients with AIDS, and the observation that HCMV
regulatory proteins can regulate expression of the Human Immunodeficiency Virus Long
Terminal Repeat (HIV LTR) (Barry et al., 1990), (Biegalke and Geballe, 1990), it has
been proposed that HCMV acts as a cofactor in the progression to and development of
AIDS. This has been supported by the colocalization of both viruses in brain cells of AIDS
patients (Nelson et al., 1988), and by the fact that under certain conditions HCMV has a
positive regulatory effect on HIV replication (Lathey et al., 1994). Some reports,
however, have revealed that HIV and HCMV do not cooperate, and in fact seem to
interfere with replication (Jault et al., 1994), (Koval et al., 1991). To date, the role of
HCMV in AIDS progression is still poorly understood, and the data obtained under
different experimental conditions are inconclusive. Therefore, the participation of HCMV
in AIDS development remains speculative.
In patients receiving allografts, HCMV represents a significant pathogen which can
cause severe post transplant complications. The source of HCMV can be reactivated virus
in the seropositive recipient, or virus harbored in the transplanted organ from a
seropositive donor. Clearly, at greater risk for primary infection are seronegative
recipients of organs from seropositive donors. Generally, the severity of HCMV infection
and disease correlates with the degree of immunosuppression of the patient. The kidney
was the first organ in which allograft transmission of CMV was observed. It was later
demonstrated that CMV can be transmitted in transplants of liver, bone marrow, heart,
and heart-lung (reviewed by Smyth et al., 1993). Between 60 and 100 % of renal allograft
recipients develop HCMV infection. Rates are similar for cardiac and hepatic
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transplantation. On the other hand, HCMV infection occurs in 32 to 70 % of bone marrow
transplant recipients. The incidence of disease caused by HCMV in the post transplant
period is between 20 and 60 %. The clinical manifestations of HCMV infection in allograft
transplant recipients include leukopenia, thrombocytopenia, lymphocytosis, elevated
hepatic transaminases, and prolonged fever. Life-threatening complications include
HCMV infection of the gastrointestinal tract, hepatitis, and pneumonia. HCMV
pneumonia is the most significant infectious syndrome in bone marrow transplant patients.
If left untreated, this complication can cause the death of 80 % of the patients (reviewed
by Britt and Alford, 1996) (reviewed by Winston, 1993).

Antiviral chemotherapy
Several antiviral agents have been used to treat HCMV disease in cases of
congenital infection, immunocompetent individuals presenting mononucleosis syndrome,
and immunosuppressed cancer and transplant patients with variable severity of clinical
symptoms (reviewed by Britt and Alford, 1996). Leukocyte interferon, interferon
stimulators such as measles virus and pyran copolymer, nucleoside drugs [iododeoxyuridine, fluorodeoxyuridine, cytosine arabinoside, adenine arabinoside (ara-A,
vidarabine), and acyclovir (ACV)] have been used individually and in combined
therapeutic regimens with little or no clinical benefit. More recently, a nucleoside drug,
9-(l,3- dihydroxy-2-propoxymethyl) guanine (ganciclovir, GCV), and phosphonoformic
acid (foscamet) have been shown to have potent antiviral properties in vitro and in vivo.
Foscamet is an inhibitor of the viral DNA polymerase. The triphosphate active form of
GCV causes nucleic acid chain termination, as well as inhibiting the viral DNA
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polymerase. GCV and foscamet have been used in cases of HCMV pneumonitis, hepatitis,
esophagitis, retinitis and colitis in patients with AIDS, as well as to treat CMV infection in
allograft recipients. However, after prolonged treatments with either GCV or foscamet,
resistance becomes a common threat. This resistance reflects the appearance of HCMV
mutant strains within the infected individual. These resistant strains contain mutations in
the DNA polymerase gene (UL54) (Baldanti et al., 1995 and 1996), (Lurain et al., 1996),
and/or in the UL97 open reading frame (ORF) (Wolf et al., 1995 and 1995), (Baldanti et
al., 1995), (Smith et al., 1996), which encodes a phosphotransferase that is required for
phosphorylation of GCV to its active form (Baldanti et al., 1995), (Sullivan et al., 1992),
(Littler et al., 1992), (Biron et al., 1986) (see Spontaneous mutants section below). It is
presently clear that new antiviral drugs need to be developed in order to efficiently control
HCMV infections. Targets in the development of these new drugs include the DNA
processivity factor (UL44 ORF), and a protease activity (UL80 ORF) (reviewed by Britt
and Alford, 1996).

Vaccines
The first trials using live attenuated vaccines to prevent CMV disease were done in
renal transplant patients. The HCMV Towne strain was used. This vims was shown to be
immunogenic in these patients, did not cause CMV-associated disease, and failed to
reactivate after the patients were subjected to immunosuppressive regimens (reviewed by
Marshall and Plotkin, 1993), (reviewed by Adler, 1995).
In the last few years, vaccine development for the prevention of HCMV disease
has been focused on subunit vaccines. Candidate HCMV proteins to be produced from
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recombinant expression systems include the major envelope glycoprotein gB, the envelope
glycoprotein gH, and the pp65 lower matrix phosphoprotein. The most promising
candidate for a subunit vaccine is gB (reviewed by Adler, 199S). When gB was cloned
into a canarypox (ALVAC) vector, and the recombinant virus (ALVAC-gB) was
administered to experimental animals, both humoral and cellular immune responses were
elicited (Gonczol et al., 199S). Moreover, human inoculations with isolated gA/gB
glycoprotein complex have been reported (Gonczol et al., 1990). CMV specific responses
of neutralizing antibodies and lymphocyte proliferation were developed in human
volunteers.
DNA vaccination has been tested with expression vectors containing UL83 ORF
(encoding the pp65 tegument phosphoprotein). Intramuscular injection of mice with these
constructs resulted in the generation of pp65 antibodies in 60% of the injected mice
(Pandeetal., 1995).

The replicative cycle
General characteristics
HCMV has a highly restricted host range in cell culture. Only cultured primary
human cells permit viral replication. The source of these cells has usually been fibroblasts
from the skin or the lungs. It is believed that cellular factors involved with differentiation
play critical roles in permissiveness for HCMV replication. For example, it has been shown
that transcription from the HCMV major immediate early promoter (MOEP) increases with
differentiation (Nelson and Groudine, 1986). More recently, Angulo and Ghazal (1995)
reported that retinoic acid (an essential regulator of cell differentiation) activated the
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MtEP and enhanced the production of virus progeny in human foreskin fibroblasts infected
with the HCMV Towne strain. The restriction on host cell range, both in cells in culture
and in vivo, is revealed by a restrictive viral gene expression, and has been proposed to
represent a postpenetration block (LaFemina and Hayward, 1986), (Nelson et al., 1987).
Cytomegaloviruses differ from many other herpesviruses in that CMV replication does not
result in the shut off of the host cell metabolism; rather, cellular DNA, RNA and protein
synthesis are stimulated by CMV. The significance of this event is still not understood
(reviewed by Mocarski, 1996). Furthermore, the HCMV envelope is not only involved in
virus attachment and entry, but also transduces signals that ultimately result info s,jim ,
and myc gene expression. In addition, HCMV infection derepresses cellular enzymes
involved in cell proliferation. The virus also induces the expression of genes involved in
cellular DNA replication, such as DNA polymerase, topoisomerase II, and ornithine
decarboxylase (reviewed by Huang and Kowalik, 1993).

Attachment and Penetration
The initial event of viral replication involves attachment of the virus to the cell
surface. Attachment occurs rapidly and efficiently, not only in permissive, but also in
nonpermissive cells. This suggests that receptors for CMV are widely distributed on the
surface of many cell types (LaFemina and Hayward, 1983 and 1986), (Nelson et al.,
1987). Compton et al. (1993) demonstrated that the virus initially attaches to extracellular
heparan sulfate proteoglycans. This interaction involves viral envelope glycoproteins,
including gB. Following this interaction, binding of the virus to specific cell membrane
glycoproteins of 32 and 34 kD occurs. These ‘Viral receptors” are present on the surface
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of endothelial, epithelial, fibroblast, and monocytic cells (Nowlin et al., 1991). In addition,
CD 13 is an aminopeptidase that seems to be involved in stable binding prior to penetration
(Soderberg et al., 1993). Penetration occurs after attachment, and it involves the fusion of
the viral envelope with the plasma membrane. Specifically, viral glycoproteins gH/gL
interact with a cellular protein of 92.5 kD (Keay and Baldwin, 1992) and annexin II
(Wright et al., 1994) (reviewed by Compton, 1995). Following penetration, the de
enveloped viral capsids are rapidly delivered to the nuclear pores, and the viral DNA is
introduced into the nucleus, where it subsequently circularizes. Once the viral DNA is
present in the nucleus, the host cell RNA polymerase II is responsible for transcribing the
viral genes.

Immediate-earlv gene expression
CMV gene expression occurs in a coordinated, sequential fashion. The viral genes
are divided into three kinetic classes, on the basis of time of expression. These classes are
immediate-early (IE), early (E), and late (L). The genes expressed first during viral
replication are the immediate-early genes. These genes are expressed without requiring de
novo viral protein synthesis. Mapping of the regions expressed at immediate-early times
during HCMV infection has revealed several areas on the HCMV genome: UL36-38,
UL122-123 (IE1/ IE2) (the major IE locus), TRS1-IRS1, and US3 (Wathen and Stinski,
1982), (Kouzarides et al., 1988), (Colberg-Poley et al., 1992), (Stenberg et al., 1984,
1985 and 1989), (Stasiak and Mocarski, 1992), (Weston, 1988). The most abundantly
expressed immediate-early genes are IE1 (UL123) and IE2 (UL122). These transcripts
arise via differential splicing, and the protein products share amino acid sequences present
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in common exons (reviewed by Stenberg, 1993), (reviewed by Mocarski, 1996).
Expression of the major IE locus is controlled by a strong transcriptional enhancer,
the major immediate-early promoter (MIEP). The structure of the M1EP presents a 5’
modulator sequence, an enhancer containing repeated elements and transcription factor
binding sites, the promoter region including the TATA box, and a leader sequence
(reviewed by Ghazal and Nelson, 1993). Both repeated elements and unique sequences are
involved in the regulation of IE transcription. A large number of known and/or predicted
cellular transcription factor binding sites, including CREB/ATF, AP-1, serum response
elements (SRE), SP1, TFHD/TBP, p53, and NFxB, among others, are central to the
transcriptional control from the MIEP. Analogous enhancers are present in the immediateearly gene locus of murine CMV and simian CMV (reviewed by Mocarski, 1996). The
initial activation of the MIEP is mediated by host cell factors and pp71 (UL82), a virion
associated tegument protein. During HCMV infection, expression from the MIEP is first
activated, then repressed. Activation differs significantly under permissive and
nonpermissive conditions, and this is independent of viral proteins (Nelson et al., 1987),
(reviewed by Ghazal and Nelson, 1993).
The protein product from IE1 is a 72 kD phosphoprotein (IE72), originally
identified as the major immediate-early protein (Stinski, 1978). The next most abundant
immediate-early gene product is encoded by IE2; this is also a nuclear phosphoprotein of
86 kD (IE86). IE1 and IE2 transcripts share the first three exons, and IE72 and IE86
share 85 amino acids at the amino terminal region. These IE proteins regulate the
expression of the immediate-early genes, as well as subsequent early gene expression.
Other minor proteins are expressed from the major IE locus. The first IE proteins
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synthesized from this region following penetration and uncoating are the 72 kD protein,
and the 55 kD protein, a positive activator of the MIEP (Baracchini et al., 1992). These
proteins appear I hr after virus adsorption. At 2.5 hs, the 38 kD, the 86 kD, and 97 kD
proteins are produced (reviewed by Stenberg, 1993).
IE72 and IE86 exert both positive and negative regulation on viral gene expression
(Depto and Stenberg, 1989), (Klucheret al., 1989), (Klucher and Spector, 1990),
(Hermiston et al., 1990), (Pizzomo and Hayward, 1990), (Cherrington et al., 1991).
Particularly relevant for the outcome of viral infection is the interaction between IE72 and
IE86 to regulate the MIEP (Stenberg et al., 1990). IE72 autostimulates its own
transcription by transactivating the MIEP via NFtcB sites, whereas IE86 is responsible for
the shut off of IE1/ IE2 expression during replication through its ability to repress MIEP
function (Lang and Stamminger, 1993). Immediate-early gene expression is reduced (a
complete shut off is not observed) during the early phase, but it is resumed late in infection
(Stenberg et al., 1989).
IE72 cooperates with IE86 and other transactivators to regulate the subsequent
cascade of gene expression. IE72 interacts with SP-1, E2F-1, and CTF-l (Hayhurst et al.,
1995), (Lukac et al., 1994), (Margolis et al., 1995). IE86 is a sequence-specific DNA
binding protein thought to be essential for the switch from immediate-early to early gene
expression. IE86 has been defined as a promiscuous transactivator. Promiscuous
activation of heterologous promoters has been found to be TATA box dependent, and
involves direct interaction with TF11D (Hagemeier et al., 1992). IE86 interacts with
several components of the cellular transcription machinery, such as TBP (Jupp et al.,
1993), TFIIB (Caswell et al., 1993), CREB (Lang et al., 1995), CBP (Schwartz et al.,
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1996), and c-jun (Scully et al., 1995). The exact mechanism used by IE86 to transactivate
is still unknown. The relative contributions of protein-protein interactions with host
transcription factors and of direct binding to DNA are still not fully understood. It has
been shown that both the amino terminal and carboxy terminal regions of EE86 are
involved in transactivation.
Although IE1 and IE2 have been shown to be central to the regulation of viral
gene expression, other immediate-early genes whose functions are still undefined are
expressed at immediate-early times. These likely play regulatory roles that influence the
outcome of infection. Additional immediate-early genes important for the regulation of
HCMV gene expression are UL36-UL38 (Colberg-Poley et al., 1992), (Kouzarides et al.,
1988), TRS1 and IRS1 (Stasiak and Mocarski, 1992), and US3 (Colberg-Poley et al.,
1992), (Weston, 1988). These genes encode products that are believed to function with
IE1 and DE2 to regulate transcription during HCMV infection.

Early gene expression
Following the immediate-early phase, the early genes are expressed (reviewed by
Mocarski, 1996). These genes are divided into subclasses on the basis of time of
expression. Using a temperature -sensitive mutant of HCMV that is impaired in DNA
replication (ts66), Stenberg et al. demonstrated that the early mRNAs are differentially
regulated relative to the time of DNA synthesis. This gave rise to the classification of the
early genes into three subclasses: those genes that are transcribed early and repressed late,
those that are expressed at equal levels at early and late times, and those transcripts that
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are produced at low levels early, and which are upregulated late (reviewed by Stenberg,
1993).
Studies on several early promoters have shown that both IE1 and IE2 are required
for maximal promoter activation (Chang et al., 1989), (Depto and Stenberg, 1989),
(Staprans et al., 1988), (Stenberg et al., 1990). Discrete sequences containing direct and
inverted repeats within early promoters have been shown to be involved in the regulation
of promoter activation (Kerry et al., 1994 and 1996). These repeated sequences vary
significantly among different early promoters (reviewed by Stenberg, 1993). In addition to
IE1 and IE2, cellular proteins, such as ATF (Kerry et al., 1997), USF (Klucher and
Spector, 1990), CREB (Lang et al., 1995), AP-1 (Wade et al., 1992), and E2F (Staprans
and Spector, 1986), have been shown to interact with HCMV early promoters to regulate
expression. It is believed that several other cellular proteins may act in conjunction with
IE1 and IE2 to regulate the expression of early promoters through the diversity of
regulatory sequences observed in these promoters (reviewed by Stenberg, 1993).
Many early genes encode viral functions involved in DNA replication. These are
the DNA polymerase (UL54), the major early single-stranded DNA binding protein
(UL57), the DNA polymerase processivity factor (UL44), and a helicase-primase complex
composed of three subunits (UL105, UL102, and UL70). HCMV DNA replication occurs
in the same series of steps as for other herpesviruses. After infection, the viral genome
circularizes in the nucleus of the infected cell. This occurs approximately 4 hs post
infection. Viral DNA synthesis peaks at 18 to 24 hs, and at 60 to 80 hs post infection.
These peaks are concomitant with cellular DNA replication (reviewed by Mocarski,
1996). HCMV DNA replication occurs from a sequence of 1.5 kbp, orilyt, between
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92,200 and 93,700 bp on the genome (Anders et al., 1992). These sequences are rich in
clustered and dispersed repeated elements. Several trans-acting factors have been found to
be required for orifyt replication. These are: UL54, UL57, UL44, UL105, UL102, UL70,
IE1 and 2 (UL122-123), UL36/UL37/UL38, TRS1/IRS1, UL112-113, and UL84 (Pari
and Anders, 1993), (Pari et al., 1993). Four of these loci (UL36-38, UL112-113, IRSl
and TRS1) cooperate with IE1 and IE2 to activate the expression of replication genes
(Iskenderian et al., 1996). DNA replication occurs by a rolling circle mechanism, and
results in the formation of concatemers.

Late gene expression
Late genes are expressed after the onset of viral DNA replication These include
structural proteins of the capsid, the tegument, and the glycoproteins of the envelope (see
section on Structure of the virion in this chapter). To date, very few late genes have been
studied in terms of the regulation of their expression. Some of the work reported has
involved the true late virion phosphoprotein pp28 (UL99) (Depto and Stenberg, 1992),
(Kohler et al., 1994), (Kerry et al., 1997), the true late gene UL94 (Wing et al., 1998),
viral glycoproteins (Geballe et al., 1986), and the IE2 late protein p40 (Jenkins et al.,
1994). Consequently, late gene expression is currently poorly understood. The reason why
these promoters are exclusively expressed at late times in infection, and what viral and/or
cellular proteins are involved in the regulation of late gene expression is still undefined.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22

Virion assembly
During the late phase, cleavage of the replicated DNA into genome length
monomers occurs. This newly synthesized DNA is inserted into maturing, pre-formed
nucleocapsids. Maturing nucleocapsids bud from the inner nuclear membrane at specific
areas o f the membrane containing viral glycoproteins. The virions then accumulate in the
perinuclear space and subsequently move into cytoplasmic vesicles. Whether the virus
follows a single path for envelopment and egress, or deenvelopment and reenvelopment in
the cytoplasm occurs, is still not clear (reviewed by Mocarski, 1996).

Identification of viral functions
The current understanding of HCMV gene function has been derived mostly from
in vitro studies. The roles of IE proteins in the regulation of viral gene expression
(reviewed by Stenberg, 1993), as well as the participation of early viral trans-acting
factors in the regulation of expression of early genes (reviewed by Spector et al., 1990),
have been defined in the context of transient expression assays. These studies have
provided important information on how viral proteins regulate expression from viral
promoters of different kinetic classes. However, they have not answered questions
regarding the essential nature of the viral genes or the actual roles of these genes in the
context of a natural infection of cells in culture.
To date, very few studies have assessed HCMV gene function during a natural
infection of cells in culture. The systems used have relied primarily on random and sitespecific mutagenesis to generate mutant viruses (see below).
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Random mutagenesis
The classical approach to study gene function in many virus families has depended
largely on conditional-lethal mutants. For animal viruses, temperature-sensitive (ts)
mutants, generated by UV or chemical random mutagenesis, have been used mostly.
Although a complete set of mutants is rarely obtained, ts mutants have been utilized
successfully to study viral protein functions of many viruses, including Herpes Simplex
virus (HSV) (Subak-Sharpe, 1974) (Schaffer et al., 1970, 1971 and 1973) (Timbury,
1971) (Esparza et al., 1974) (Bone and Courtney, 1974) (Brown et al., 1973) (Marsden et
al., 1976), (Preston et al., 1988), (Weiretal., 1989).
In contrast, very few HCMV ts mutants have been isolated and characterized to
date (reviewed by Stenberg, 1993), (reviewed by Mocarski, 1996). Yamanishi and Rapp
(1977) initially isolated eight ts mutants obtained by mutagenesis with nitrosoguanidine. A
total of twenty-one ts mutants had been isolated and reported by 1979 (Yamanishi and
Rapp, 1979). Four of these mutants were DNA-negative mutants belonging to different
complementation groups. These mutants were used to demonstrate that viral DNA
synthesis is not required for the HCMV-induced cellular DNA replication. Attempts to
generate mutants with S-bromodeoxyuridine were unsuccessful. Stenberg isolated an
HCMV ts mutant (ts 66) that is impaired in DNA replication. This mutant was useful to
study the differential regulation of transcription of several early genes relative to the time
of viral DNA synthesis (reviewed by Stenberg, 1993). In contrast with the scarcity of
HCMV ts mutants, as many as 24 complementation groups of MCMV ts mutants have
been isolated and analyzed (Tonari and Minamishima, 1983), (Sammons and Sweet,
1989), (Akel et al., 1993).
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Although ts mutants have traditionally played an important role for defining gene
function, there are some problems inherent to them. First, ts mutants produced by UV or
chemical random mutagenesis may contain numerous silent nonlethal mutations in several
genes. In addition, if a ts mutation is introduced into the DNA sequence encoding a
domain shared by more than one viral function, the resulting phenotype cannot be
correlated to a particular viral gene. Lastly, in many instances, tight ts mutants are hard to
obtain; leakiness is revealed by plating efficiencies with a low permissive to nonpermissive
ratio, and this complicates the analysis o f the resulting phenotype.

Site-specific mutagenesis
As an alternative to random mutagenesis, site-specific insertion or deletion of
genes was first developed for the study of HSV gene function by Post and Roizman in
1981. This protocol is based on the generation of recombinant viruses obtained as a result
of the double recombination between intact viral DNA and a DNA fragment containing
the mutation (deletion or insertion), and a selectable marker. Using this approach, viable
mutants can be obtained as long as the deletions or insertions affect genes that are
dispensable for growth of the virus in culture. In order to be able to generate recombinant
viruses with mutations in essential genes, the original recombination protocol had to be
adapted by generating a host cell line expressing the gene that complements the mutation
in the recombinant virus. These complementing cells allow for the propagation of the null
mutants.
For HCMV, deletion mutants have been generated by inserting prokaryotic
reporter genes, such as (3-galactosidase and P-glucuronidase, into the viral genome
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(Spaete and Mocarski, 1987), (Jones et al., 1991), (Jones and Muzithras, 1992), (Ripalti
and Mocarski, 1991), (Takekoshi et al., 1991), (Browne et al., 1992), (Kaye et al., 1992).
Using this approach, Jones et al. demonstrated that the US 10 and US11 gene products are
nonessential for viral replication in cells in culture. By constructing a deletion mutant using
a similar approach, Kaye et al. showed that the UL16 gene encodes a glycoprotein that is
nonessential for replication of HCMV in culture. Similarly, Browne et al. demonstrated
that the UL18 gene, which encodes the viral homologue of the cellular MHC Class I heavy
chain, is dispensable for growth of the virus in human fibroblasts in culture. Thus, these
procedures have allowed for the isolation of viruses with nonlethal mutations, namely,
viruses with deletions of genes that are dispensable for the replication of HCMV in tissue
culture. These deletion mutants have allowed for the definition of 41 ORFs dispensable for
growth of HCMV in vitro. These ORFs are TRL4 -TRL14, UL1 - UL10, UL16, UL18,
UL20, UL33, UL128, IRS1, US1 - US13, and US27. The protein products of most of
these genes have still not been defined, but they are believed to play critical roles in viral
pathogenesis within the natural host.
Because only primary human cells are permissive for HCMV replication in culture,
the identification of essential genes has been hindered due to the lack of permanent cell
lines to complement virus null mutants. In the last two years, reports by Mocarski et al.
(1996) and Greaves and Mocarski (1998) represent the first attempts to generate
recombinant HCMV with mutations in putative essential genes. Using cosmids derived
from the Toledo and Towne strains, Mocarski et al. generated an HCMV mutant deleted
of the IE1 gene. The protein product o f TE1 (IE72) has long been thought to be essential,
but direct experimental evidence supporting this notion is lacking. In addition, Greaves
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and Mocarski isolated a second DEI deletion mutant, which lacked exon 4 o f the major IE
locus. The IE 1-negative viruses were propagated in an IE 1-expressing human fibroblast
cell line (ihfie 1.3). At low multiplicities of infection (MOIs), the deletion mutants failed to
replicate in human fibroblasts in culture. However, at MOIs of more than 3 plaqueforming units (PFU) per cell, virus yields were comparable to those of wild type virus. The
authors speculated that at high MOIs, the IE 1-deficient viruses are capable of growing
with wild type kinetics due to compensation for the lack of the IE1 gene product by virion
transactivators, which could function in place of IE 1 to regulate the initial events of the
cascade of HCMV gene expression.

Spontaneous mutants
Spontaneous mutants have also been useful for elucidating the functions of HCMV
genes. For example, Zipeto et al. (1993) identified a spontaneous HCMV deletion mutant
lacking the pplSO matrix phosphoprotein gene. Together with pp65, pplSO is the main
component of the viral matrix. The authors failed to plaque-purify the deletion mutant,
therefore they concluded that the variant was growth-defective and dependent on coinfecting wild type virus for replication. This suggested that pplSO is an essential viral
function.
Several spontaneous HCMV drug resistant mutants have been isolated from
individuals undergoing antiviral treatments with ganciclovir or foscamet (see Antiviral
chemotherapy section in this chapter). These mutants have been very valuable tools for
analyzing the efficacy, selectivity and mode of action of these antiviral drugs, as well as for
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identifying the viral gene functions that are targets of these drugs: the UL97 and UL54
genes.

The number of HCMV mutants isolated and studied to date is clearly insufficient
to unveil the roles of the more than 200 predicted ORFs in the AD 169 genome. Because
only very few HCMV ts mutants have been generated, and because the lack of
complementing cell lines has prevented the generation of HCMV null mutants, a
significant number of viral essential gene functions have not been defined yet. In contrast,
as mentioned above, deletion mutants have allowed for the definition of 41 ORFs
dispensable for growth of HCMV in vitro.
At present, our understanding of the HCMV DNA coding capacity is mostly based
on comparisons with HSV-1. Approximately 25 % of the ORFs are predicted to code for
functions involved in viral DNA replication and metabolism, and the remaining 75 % is
believed to code for structural proteins, and proteins involved in virion maturation
(reviewed by Mocarski, 1996). Clearly, alternative methods need to be designed to study
HCMV essential gene functions in the complex genetic environment of the HCMVinfected cell. These methods should allow for the stringent control of gene expression in
order to be able to define the roles of individual viral gene products. Some of these
methods are discussed in the following section.
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Inducible systems for the study of gene expression
Inducible expression systems in mammalian cells
Inducible expression systems have been used to elucidate the function of many
genes in bacteria, yeast, and Drosophila sp. Recently, similar strategies have been
developed for mammalian cells. Some of these systems consist of promoters that are
induced by endogenous control elements, such as promoters responsive to heavy metal
ions (Mayo et al., 1982), (Brinster et al., 1982), (Searle et al., 1985). Other systems
consist of promoters responsive to heat shock (reviewed by Nouer, 1991) or hormones
(Hynes et al., 1981), (Klock et al., 1987), (Israel and Kaufman, 1989). All of these
systems have generally suffered from leakiness of the inactive state and, in some cases
such as the metallothionein promoter (Mayo et al., 1982), (Brinster et al., 1982), or the
mouse mammary tumor virus promoter (Hynes et al., 1981), they show rather modest
levels of induction. More importantly, the induction of transcription in these systems
results in pleiotropic effects caused by the inducers themselves. For example, elevated
temperature or glucocorticoid hormones (Lee et al., 1988) affect the expression of many
cellular genes, in addition to the gene under study. This complicates the analysis of the
resulting phenotype.
In an attempt to create highly specific regulatory circuits controlled by exogenous
effectors, inducible systems that exploit prokaryotic elements have been constructed for
the study of gene activity in higher eukaryotic cells. Bacterial regulatory proteins and
operator sequences are particularly useful to control transcription in mammalian cells. A
distinct advantage is that the recognition DNA sequence (the operator) for the regulatory
protein (the repressor) is relatively unique to the gene being studied (Simons et al., 1984).
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Thus, monospecific control systems, which are modulated by effectors that are inert to the
physiology of the cell, can be established in eukaryotic cells.

The Escherichia coli lac operon
Some systems utilized to study inducible gene expression in mammalian cells are
based on the Escherichia coli lac operon. The operon model (a cluster of genes encoding
enzymes of a particular metabollic pathway that are controlled by a single promoter from
which a single polycistronic mRNA is transcribed) was proposed by Jacob and Monod.
This operon is the classic example of negative regulation of transcription by a repressor
protein. The elements in this operon include a regulator gene ( / ) encoding the repressor,
which is under the control of a separate promoter that regulates its constitutive
expression, an operator site within the operon promoter, and a set of three contiguous
structural genes (z ,y , a) encoding the inducible enzymes P-galactosidase, galactoside
permease, and thiogalactoside transacetylase, respectively. For Escherichia coli, the
physiologic inducer is allolactose, which is formed from lactose by transacetylation.The
/ gene produces a 37 kD polypeptide that aggregates to form a tetrameric repressor
protein. Each subunit consists of 360 amino acids, with a total molecular weight of
154,520. The lac operator is a 27 base pair DNA sequence containing a 16-base
hyphenated palindrome. It presents 2-fold symmetry that matches the symmetry of the
tetrameric repressor. The tetramer binds to the operator very tightly and rapidly when
E coli is grown in the presence of glucose or glycerol and in the absence of lactose. This
binding results in the block of transcription of the structural genes. As a result, |3galactosidase, an enzyme that is required to hydrolize lactose to galactose and glucose, is
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present at very low levels (5 -1 0 molecules per cell). However, when lactose, but not
glucose, is present in the culture medium, the inducer (allolactose) binds to the repressor
with high affinity, and causes an allosteric change in conformation that drastically reduces
the affinity of the repressor for the operator. This results in transcription of the structural
genes, and the concentration of P-galactosidase increases to several thousand molecules
per cell.
The lac repressor-operator interaction has been thoroughly characterized
(reviewed by Miller and ReznikofF, 1980). The dissociation constant of the repressoroperator complex is 10'13 M.The rate constant for association (* 1010M"1s l) is very high,
which indicates that random association with and dissociation from the DNA is probably
not the mechanism for repressor binding to the operator. Rather, it is suggested that
facilitated transfer of the repressor to the operator occurs (Fickert et al., 1992). The
tetrameric repressor associates to DNA in a nonspecific manner, and this is followed by a
looping event that brings the repressor in contact with the operator. This is known as the
intersegment transfer mechanism. The lac repressor binds 4x106 times more strongly to
its operator than to other sites on the chromosome. These characteristics of the lac
repressor-operator interaction are essential for the application of a highly specific
regulatory system for the study of gene expression in eukaryotic cells.

The lac repressor-operator gene expression system in eukaryotic cells
Brown et al. (1987) was one of the first groups to test the lac repressor-operator
system in mammalian cells. They used the chloramphenicol acetyl transferase (CAT)
reporter gene driven by operator-containing variant SV40 early promoters. Repression
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was observed when the reporter constructs were cotransfected with a plasmid encoding
the lac repressor. Isopropylthiogalactoside (IPTG), a non-metabolizable inducer, was used
to relieve repression. The same group described the regulation of a stably integrated CAT
gene by the lac repressor in monkey cells (Figge et al., 1988).
In 1987, another report on the use of the lac repressor-operator system in
mammalian cells presented evidence that the lac repressor produced in mouse cells can
block transcription from an unintegrated CAT gene driven by the Moloney sarcoma virus
enhancer containing a lac operator insertion. Derepression was observed when cells were
exposed to IPTG (Hu and Davidson, 1987). Later, this group proceeded to combine the
repressive / inducible lac system with induction by glucocorticoids and metal ions in order
to achieve higher levels of inducibility. The system presented a high-level-inducible
promoter (containing a lac operator sequence and a metal-responsive element) that was
regulated by both derepression of the lac repressor system, and induction by
glucocorticoid and Cd2+ (Hu and Davidson, 1990).
Other reports have shown the successful application of the lac repressor- based
gene expression system in mammalian cells. Deuschle et al. (1989) utilized the lac
repressor protein and the coliphage T3 RNA polymerase to regulate transcription of the
firefly luciferase gene downstream of a phage T3 promoter containing a lac operator
sequence, in rabbit kidney cells. Repression factors comparable to those observed in
prokaryotes were obtained. In addition, the lac repressor system was used efficiently to
regulate expression of genes transcribed by RNA polymerase m in mammalian cells
(Syroid et al., 1992).
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A different approach for utilizing the lac repressor protein to control mammalian
gene expression was developed by Labow et al. (1990). They converted the lac repressor
into a mammalian transcriptional activator by fusing the transcription activation domain
from the HSV-l virion protein 16 (VP 16). This fusion protein (LAP) was a potent
activator of various promoters containing up to 21 lac operator sequences in different
positions relative to the transcription start site. The activation was efficiently inhibited by
IPTG, although it never completely eliminated activation by LAP.
The versatility of the applications of the lac repressor-based system is also
illustrated by the adaptation of the system for the regulation of gene expression in plant
cells (Wilde et al., 1992), as well as the utility of the system to study the interactions
between HCMV and HTV-1 to control viral gene expression in brain cells (Moreno et al.,
1997).

Lac-regulated vaccinia virus gene expression
Most of the work published to date reporting the use of the lac repressor-operator
system for the study of gene expression in eukaryotic cells has been done with vaccinia
virus. Rodriguez and Smith (1990) adapted the lac repressor-operator system to study
inducible gene expression in vaccinia virus. Recombinant viruses containing the lac i gene
and the lac operator sequence were generated, to study the vaccinia virus gene encoding a
14 kD membrane protein. They demonstrated that this viral protein is not essential for the
production of intracellular progeny virus, but it is absolutely required for the envelopment
of the virus particles in the Golgi apparatus prior to egress from the cell.
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Zhang and Moss (1991), (Zhang et al., 1992) constructed recombinant vaccinia
viruses constitutively expressing the lac repressor, and containing lac operator sequences
in endogenous promoters, to study the roles of vaccinia virus genes F18R and G8R. From
these studies it was concluded that the F18R gene product, an 11 kD virion associated
protein, is required for virion assembly. In addition, the G8R gene product was shown to
be an essential late transcription factor. Other genes studied by this group include genes
involved in virus morphogenesis, such as D13L (Zhang and Moss, 1992), D6R (Hu et al.,
1996), and A8L (Hu et al., 1998) genes. Using the lac repressor-operator system, all of
these genes were shown to encode proteins that are essential for viral assembly.
Recently, a different group of investigators (Klemperer et al., 1997) used the lac
repressor-operator system to construct an inducible II gene in recombinant vaccinia virus.
They found that the 35 kD protein product, which is expressed at late times during
infection, is essential for the latest stages of viral assembly.

The Tetracycline repressor system
Another inducible system utilizing the E.coli Tetracycline (Tet) resistance operon
has been developed to control gene expression in mammalian cells. The Tet resistance
operon and the lac operon regulate gene expression in a similar manner. One of the
applications of this system includes the fusion of the tetracycline repressor with the Herpes
simplex virion transactivator VP 16 to generate a chimeric transactivator that can be
regulated by tetracycline (Gossen and Bujard, 1992), (Kim et al., 199S). Kim et al. used
the tetracycline repressor fused to VP16 (tTA) to regulate expression of the
^-glucuronidase reporter gene driven by tetracycline operator-containing promoters
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derived from the HCMV US 11 promoter. In transient assays, efficient repression was
observed when two or three tetracycline operator sequences were placed adjacent to the
TATA box. Repression was also significant in cells constitutively expressing tTA that
were infected with recombinant HCMV containing the operator derivative of the US 11
promoter driving the expression of the (3-glucuronidase gene. This repression was
efficiently relieved by tetracycline.

The HCMV US9 gene: a target for testing lac repressor-mediated control of HCMV
gene expression
In the following chapters, a comprehensive analysis of the expression of lac
operator-containing, HCMV US9 promoters is presented. This analysis is central to the
main objective of this project, which was to test the lac repressor-based system using an
HCMV specific promoter. Subsequently, because of the nonessential nature of the US9
gene for HCMV replication in human fibroblasts in culture (Jones and Muzithras, 1992)
(see below), the endogenous US9 promoter can be targeted for conditional expression
using the lac repressor system, without jeopardizing the production of virus progeny, or
having virus growth dependent on IPTG. The feasibility of this approach to study HCMV
gene expression can therefore be assessed. Parameters of repression and IPTG
derepression can be tested and optimized, without compromising the production of
progeny virus to any of these variables. These experiments will significantly contribute to
the long-term goal of the project: to apply the lac repressor-based system to study the
roles of putative essential HCMV genes in the context of a natural infection of cells in
culture.
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The US9 gene encodes an envelope glycoprotein whose exact role during HCMV
infection is still unknown. This gene is contained within the Hind EQ X region of the
HCMV AD 169 strain. The genes contained in this region have been defined as the US6
gene family (US6 through US 11). The members of this gene family encode proteins of
about 180 - 250 amino acids. They present hydrophobic regions at their amino and
carboxy termini, and a signal sequence and transmembrane domain have been identified.
These proteins also contain N - X - T/S N-linked glycosylation addition sequence. All this
evidence has suggested that the US6 gene family encodes related glycoproteins.
The US6 family members have been shown to be dispensable for growth of
HCMV in human fibroblasts in culture. This was demonstrated by Jones and Muzithras
(1992), who generated a series of recombinant HCMV by inserting the (3-glucuronidase
gene into the HCMV genome in a manner that resulted in the deletion of one or more of
the US6 gene family members. The recombinant viruses grew with similar kinetics to wild
type virus. On the other hand, in a study on retinal CMV disease, Pereira et al. (1995)
demonstrated that viruses with deletions in US9 and US8 / US9 were not capable of
spreading from cell to cell, and infection of polarized retinal pigment epithelial cells with
these viruses resulted in the formation of smaller plaques. It was concluded that the US9
glycoprotein is essential for spread of the virus in these cells. More recently, Maidji et al.
(1996) used HCMV deletion mutants to demonstrate that the US9 accesory glycoprotein
is essential for cell-to-cell transmission of the virus in polarized human retinal pigment
epithelial cells. When HCMV mutants deleted in US9 were compared with HSV-1
deletion mutants that are unable to express glycoproteins gE and gl, both HCMV and
HSV-1 mutants were impaired in spread across lateral membranes of the infected cells.
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In terms of the expression of the US9 gene, Jones and Muzithras (1991) demonstrated
that the 1.7kb US9-US8 transcript is expressed with early kinetics. They showed that this
mRNA was most abundant at 24 hs post infection, and its abundance was greatly reduced
by 48 to 72 hs post infection.
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CHAPTER n
SPECIFIC OBJECTIVES
The aim of this study was to construct an Escherichia coli lac repressor-based
system to control HCMV gene expression. The system includes the lac repressor protein
(encoded by the lac i gene), its cognate operator DNA sequence, and the specific inducer
IPTG. In order to test the feasibility of this approach to study HCMV gene expression, a
lac repressor expressing HCMV (RVlac) was generated by homologous recombination
resulting in the insertion of the lac i gene into a region of the HCMV genome that is
dispensable for growth of the virus in culture. RVlac was used to assess lac repressor
protein production in RV/ac-infected cells in culture, as well as lac repressor activity using
operator-containing HCMV US9 promoters in transient assays. In these assays, the
appropriate number and relative position of the operator sequences could be determined
for effective /ac-mediated repression of the operator-containing US9 promoters, and
restoration of promoter activity by IPTG.
The promoter of the US9 gene was chosen for this study because: a) this gene is
known to be nonessential for virus replication in tissue culture, and b) the US9 gene is
adjacent to the site of insertion of the lac i gene, so insertion of both the operatorcontaining US9 promoter in place of the endogenous promoter and the lac i gene could be
accomplished in a one step recombination event. Because of the nonessential nature of the
US9 gene, future analysis of parameters of repression and derepression of operatorcontaining promoters can be performed in the endogenous locus, without having virus
growth dependent on IPTG. In this way, the feasibility of this approach to control HCMV
gene expression in the context of the viral genome could be tested.
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This conditional expression system would allow assessment of the functional roles
of HCMV putative essential gene products during viral replication. HCMV putative
essential genes can be targeted for conditional expression by constructing recombinant
viruses containing lac operator sequences in their promoters. These promoters can be
acted upon by the lac repressor produced from the same recombinant virus or a
coinfecting recombinant HCMV. In this way, the effect of the loss of expression of the
target gene on virus replication can be addressed.

The specific objectives of this study were:
1) To generate recombinant HCMV that expresses the lac repressor (KWlac). The gene
encoding the lac repressor (lac i gene) was inserted into the HCMV genome by
homologous recombination. The strategy involved the replacement of the marker gene 13glucuronidase (P-giu) in the US9-US10 intergenic region of the RV134 (parental
recombinant HCMV) genome. RV/ac was characterized in terms of lac repressor protein
expression, and repression capabilities of the lac repressor produced, using operatorcontaining heterologous promoters in transient assays.
2) To construct operator-containing US9 promoters. The lac operator sequence was
positioned at different sites within the US9 promoter. The resulting variant promoters
were inserted into the viral genome (specific objectives 3 and 4), and tested for promoter
expression (specific objective 6).
3) To generate recombinant HCMV containing operator-containing US9 promoters
(RVUS9op). Operator-containing US9 promoters were inserted into the viral genome by
homologous recombination, as described in specific objective 1. The resulting recombinant
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viruses contained the operator-containing US9 promoter in the endogenous locus. To
validate the use of these operator-containing promoters for future analysis of conditional
US9 gene expression in the context of the viral genome, US9 gene expression was
examined (steady-state levels of US9 mRNA) in RVUS9op-infected cells to control for
the impact of the operator insertion in the US9 endogenous locus.
4) To generate recombinant HCMV containing the lac / gene and the operator-containing
US9 promoter (RV/acUS9op). The construction and isolation of RV/acUS9op was
pursued in order to obtain a recombinant HCMV that would contain the complete
conditional expression system for analysis in the context of the viral genome. The gene
encoding the lac repressor and the operator-containing US9 promoter were inserted into
the viral genome as described in specific objectives 1 and 3.
5) To analyze the growth properties of the recombinant viruses in vitro. One step
growth curves were performed to determine if the insertion of the lac i gene and/or the lac
operator sequence in the HCMV genome has an impact on the rate of virus replication.
6) To assess expression of operator-containing US9 promoters. The operator-containing
US9 promoters were tested in CAT reporter constructs in transient assays, in order to
analyze the intrinsic effect of the operator insertion on promoter activation by HCMV
immediate-early proteins IE1 and IE2, or wild type AD 169 virus. In addition, RVlacmediated repression of these promoters in CAT reporter constructs, and the ability of
IPTG to restore promoter activity were assessed.
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CHAPTER m
MATERIALS AND METHODS
Cells. Primary human foreskin fibroblasts (HFF) were grown in Minimum Essential
Media Eagle (MEM) (Gibco BRL, Rockville, MD), supplemented with 10% heatinactivated newborn calf serum (Gibco BRL, Rockville, MD), 0.03 % L-glutamine
(Sigma, St. Louis, MO), 0.006 % Penicillin (Sigma, St. Louis, MO), and 0.01 %
Streptomycin (Sigma, St. Louis, MO). HFF cells were passaged weekly. COS-1 cells
(African green monkey, SV40 transformed kidney fibroblasts) were obtained from the
American Type Culture Collection (ATCC) (ATCC Number: CRL-1650, Rockville, MD)
(Gluzman, 1981), and were propagated in MEM, containing S% heat-inactivated fetal calf
serum (Gibco BRL, St. Louis, MO), 0.03 % L-glutamine, 0.006 % Penicillin, and 0.01 %
Streptomycin. All cells were incubated at 3 7 0 C, 5% CO2 .
Viruses. The viruses used in this study were the HCMV strain AD 169 and its
derivative RV134, containing the Escherichia coli (3-glucuronidase marker gene, under
the control of the 2.7 HCMV early promoter, and inserted in the US9-US10 intergenic
region of the AD 169 genome. RV670, a recombinant HCMV deleted of IRS 1, US1
through USS, and the US6 family, was obtained from Dr. T. Jones (Jones and Muzithras,
1992). Viruses were grown in cultured primary human foreskin fibroblasts (HFF) for the
preparation of high-titer stocks. The stocks were titered by plaque assay in HFF cells,
using standard procedures.
Plasmid constructions. Standard plasmid cloning and plasmid preparation
techniques were performed (Maniatis et al., 1987). Restriction endonuclease digestion
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protocols were conducted as suggested by the manufacturers (Promega, Madison, WI,
New England Biolabs, Beverly, MA).
Plasmid pMIEP/ac / (shown in Figure 1) was constructed by inserting the 1.6
kilobase (kb) Escherichia coli lac i gene in place of the IE I cDNA downstream of the
HCMV major immediate-early promoter (MIEP) in the pIE72kD expression vector. The
MIEP consists of a HindiII to &/II fragment of 800 nucleotides derived from plasmid
p760CAT (Stinski and Roehr, 1985), obtained from Dr. Stinski, and the 1.8 kb IE 1 cDNA
(encoding the HCMV immediate-early protein IE72) is a Ss/II to HindiII fragment. The
lac i gene (modified to include the SV40 T antigen nuclear localization signal) was derived
from the p3’SS eukaryotic Lac Repressor expressing vector in the Lac Switch inducible
mammalian expression system (Stratagene, La Jolla, CA). A unique Xbal site 15
nucleotides upstream of the 5’end of the lac i gene was used to linearize p3’SS. The linear
DNA molecules were extracted with phenol, and subsequently with chloroform. Following
ethanol precipitation, these molecules were treated with DNA Polymerase Large (Klenow)
fragment (New England Biolabs, Beverly, MA). Previously kinased &/II linkers were then
ligated to the linear vector. The resulting clones were screened for the presence of the
&/II linkers. Digestion of pIE72kD with 5 5 /D, followed by partial digestion with
Hindm, and ligation of the &/Q to Hindlll 1. 6 kb fragment containing the lac i gene,
allowed for the generation of pMIEP/ac i.
Plasmid pRVMIEPlac i was constructed by inserting the MIEP-/ac / gene H indm
cassette derived from plasmid pMIEP/ac /, into a unique Hind m site upstream of the
US9 promoter in the recombination vector pRV3 (shown in Figure 3). This Hindm site
was generated by inserting a BamHl -Xbal -Hindlll linker into a unique Apal site in the
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US9-US10 intergenic region (5’GGGATCCGCTCTAGAGCAAGCTTGGGCC3’).
pRV3 contains genes from a nonessential region of the HCMV genome (US8 through
US11) that provide the appropriate flanking sequences to allow homologous
recombination into the viral genome. The clone in which the orientation of the lac i gene
conforms to the direction of transcription of the neighboring genes was isolated.
Plasmid pUS9CAT (Figure 11) was constructed by cloning the US9 promoterleader as a 310 nucleotide (-269 to +41) Hindlll fragment, from pRV3 (which had been
modified with the insertion of a Hindlll site into the 5 5 /1 1 site at +40 in the leader
sequence), into a unique Hindlll site upstream of the chloramphenicol acetyl transferase
(CAT) gene in pSVOCAT.
Plasmid pUS9opCAT (shown in Figure 11) was generated by inserting the lac
operator sequence 5’GAATTGTGAGCGGATAACAATTTC3’ flanked by Sstll linkers
into a unique 5 5 /1 1 site at nucleotide position +40 in the leader sequence of the US9
promoter-leader in pUS9CAT.
To generate pUS9op(-16)CAT and pUS9op(-6)CAT (shown in Figure 11), the lac
operator sequence 5’GAATTGTGAGCGGATAACAATTTC3’ was inserted at different
alternative sites in proximity to the TATA box within the US9 promoter, by an
overlapping PCR mutagenesis strategy (shown in Figure 12) based on modifications of
PCR protocols previously described (Zhang and Moss, 1991). Two operator-containing
US9 promoters, US9op(-16) and US9op(-6), with the lac operator sequence 16 or 6
nucleotides upstream of the transcription start site, respectively, were generated using
plasmid pUS9CAT as a template. Two separate PCR reactions were conducted for each
operator-containing promoter. For the first reaction, primers pSVOl’:
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5’GCTCTGATGCCGCATAGTTAAGCC 3’, and US92: 5’
GCCTCTTTATATCGTCCCGACGTGACGCG 3’ were utilized. For the second reaction,
the primers used were US93: 5’
CGCGTC ACGTCGCtGACGATATAAAGAGGCAGAATTGTGAGCGGATAACAATT
TCCGGTGTTTCGGCTCCCGCAC 3’ (underlined sequence represents operator at -16)
or US93’: 5’
CGCGTCACGTCGGGACGATATAAAGAGGCACGGTGTTTCGGAATTGIGAGCG
GATAACAATTTCGCTCCCGCAC 3’ (underlined sequence represents operator at -6 ),
and CAT4’: 5’ GCGGGCAAGAATGTGAATAAAGGCCGG 3’. For each operatorcontaining promoter, these reactions rendered two overlapping products, which were
subsequently treated with DNA Polymerase Large (Klenow) fragment (New England
Biolabs, Beverly, MA), and then mixed together and PCR amplified using primers
pSVOl’ (5’-most), and CAT4’ (3’-most), to generate the final operator-containing
product. The final product was digested with Hindlll, purified by electrophoresis in 5%
polyacrylamide, and ligated into //mc/IIl-linearized pSVOCAT, to generate
pUS9op(-16)CAT (operator at -16) or pUS9op(-6)CAT (operator at -6 ). The presence of
the operator sequence in these constructs was confirmed by DNA sequencing (Pharmacia
LKB.A.L.F. DNA Sequencer, Piscataway, NJ).
Recombination plasmids pRVUS9op-16 and pRVUS9op-6 (Figure 11) were
constructed by inserting the operator-containing US9 promoters derived as HirtdUl to
Ssfll fragments from pUS9op(-16)CAT and pUS9op(-6)CAT, respectively, in place of the
US9 promoter (removed as a Hindlll to &/II fragment) in pRV3.

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

44

Recombination plasmids pRV/acUS9op-16 and pRV/aclTS9op-6 (shown in
Figure 11) were derived from pRVUS9op-l6 and pRVUS9op-6, respectively, by
inserting the MIEP-/ac / gene Hindlll cassette [derived from plasmid pRVMIEP/ac /
(Figure 3)] into a unique HindUl site upstream of the US9 promoter. The resulting clones
were screened for orientation of the MIEP-/ac / gene cassette using Ss/H Clones in which
transcription of the lac i gene proceeds in the same direction as the neighboring genes
were isolated.
Plasmids pOpl3CAT and pOpRSVICAT (shown in Figure 8 A) were obtained
from the Lac Switch inducible mammalian expression system (Stratagene, La Jolla, CA).
Plasmid pSVH (Depto and Stenberg, 1989) was obtained from Dr. Stenberg. This
expression vector contains the genes encoding the HCMV immediate-early proteins IE1
and IE2.
DNA preparations. Infected HFF DNA was isolated using the Genomic Prep Cells
and Tissue DNA isolation kit (Pharmacia Biotech, Piscataway, N.J.) following the
manufacturer’s suggestions. DNA was quantitated on a spectrophotometer (Milton Roy
Spectronic 1001 Plus) at 260 nm.
RNA preparations. Total RNA was isolated from infected HFF cells using the
Qiagen Rneasy kit (Qiagen, Chatsworth, CA). The protocol was conducted as described
by the manufacturer. RNA was quantitated on a spectrophotometer (Milton Roy
Spectronic

1001

Plus) at 260 nm.

Construction of recombinant HCMV. Recombinant viruses expressing the lac
repressor, and/or containing a lac operator sequence in the US9 promoter in the
endogenous locus were generated by a homologous recombination strategy involving the
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replacement of the ^-glucuronidase (fi-glu) marker gene in the US9-US10 intergenic
region of the RV134 (parental recombinant HCMV) genome (see Figure 4). Homologous
recombination resulted following cotransfection of infectious RV134 DNA and linearized
recombination plasmid DNA into cultured primary human foreskin fibroblasts using a
modification of the calcium phosphate precipitation procedure described in Current
Protocols in Molecular Biology (1996, Volume 1, Unit 9.1, Supplement 36) (Ausubel et
al., 1996). 8 ug of RV134-infected cell DNA and 1-2 ug of CsCl-purified, &i/I-linearized
recombination plasmid DNA were added to 4S0 ul of sterile distilled water, followed by
the addition of 50 ul of a 2.5 M CaCl2 solution. After gentle mixing, 500 ul of 2X Hepesbuffered saline (38.4 mM Hepes, 274 mM NaCl, 10 mM KC1,

1 .6

mM Na2 HPO4 , 0.2%

dextrose, pH 7.05) were added dropwise to the DNA-CaCl2 mix, using a Pasteur pipette
to mix gently. The DNA precipitate was allowed to form by incubating the mix at room
temperature for 15 minutes. The DNA precipitate was then added dropwise onto a
monolayer of primary human foreskin fibroblasts in a

100

mm-tissue culture plate,

previously washed with 5 ml of IX Hepes-buffered saline. After an 8 -minute incubation at
room temperature, 10 ml of HFF culture media were added. This was followed by
incubation at 37° C for 4 hs. At this time, cells were shocked using 2 ml of a 15% glycerol
solution, to increase the cellular uptake of DNA. After 45 seconds, the glycerol was
removed, and 5 ml of HFF culture media were quickly added to wash out remaining
glycerol. The media was removed 20 seconds later, and 15 ml o f fresh culture media were
added. Transfected cells were incubated at 37° C, with regular changes of fresh media
every 4 days. Approximately 10 days after transfection, the first signs of cytopathic effect
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(CPE) were visible. When transfected cells reached 100% CPE, primary stocks of putative
recombinant virus were harvested and stored at -80° C.
Isolation of recombinant HCMV. To identify the primary stocks that contained
recombinant virus in addition to parental virus, the stocks harvested as described above
were initially screened by PCR. HFF cells were infected with the primary stocks at a
multiplicity of infection (MOI) of 2 plaque forming units (PFU) per cell, and at 72 hs post
infection, cells were harvested and total infected cell DNA was isolated. For the
identification of lac /-containing recombinant viruses, lac /-specific primers P3:
5’CTCCCACCATGAAACCAGTAACG 3 \ and M2:
5’GGTATCGTCGTATCCCACTACCG 3’ were used. These primers amplified
835 nucleotides within the lac i gene. US9 promoter-specific primers
US9opTC(scr)l: 5’ CCATATAAACGTGGGTTTCGGTGACCACAACC 3’, and
US9op(scr)3: 5’ GACACCAGTGCCAGAAGAAGGAACAGGTGGAC 3’, were used for
screening for operator-containing recombinant viruses. These primers amplified
318 nucleotides containing the wild type US9 promoter. The presence of the
24- nucleotide lac operator sequence resulted in the generation of a PCR product of
342 nucleotides. The screening of primary stocks was also conducted by western blot
analysis, for the identification of stocks containing recombinant viruses expressing the lac
repressor, using an anti-/ac / polyclonal serum (Stratagene, La Jolla, CA) (see western
blot analysis section below). In addition, the screening involved Southern blot analysis
using a lac /-specific probe (see Southern blot section below). Southern blot analysis was
also conducted using an AD 169 Hindm X probe (spanning the HCMV AD 169 genomic
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region US7 through US11), for the identification of primary stocks containing
recombinant viruses (see Southern blot analysis section below).
Following the identification of primary stocks containing recombinant viruses,
these pools of virus were screened by altered plaque phenotype (blue plaques [parental
R.V134] or white plaques [recombinant]) in the presence of the chromogenic substrate for
3-glu: 5-bromo-4-chioro-3-indolyI-3-D-glucuronide (X-glu) (Biosynth AG). This allowed
for the isolation of recombinant viruses. HFF cells in monolayer were infected with
primary stocks at an MOI of 10 PFU per plate. After adsorption of the virus at 37° C for
2 hs, the inoculum was removed, and 10 ml of fresh culture media were added. 24 hs after
infection, the infected cells were overlayed with minimum media (MEM) (Fisher Scientific,
Pittsburg, PA) containing 10% heat-inactivated fetal calf serum, and 0.5% agarose. Cells
were fed by additional overlays weekly. When plaques became visible macroscopically
(approximately 2-3 weeks after infection), plaques were picked as agarose plugs, placed in
individual wells of 24 well culture dishes, and incubated until CPE became visible. At that
time, the cells were overlayed as described above, with the addition of 75 ug per ml of
X-glu. After 3 days, wells with a clear overlay were considered negative for
3-glucuronidase activity, suggesting the presence of recombinant virus.
Individual plaques were picked from clear wells as agarose plugs, and the virus
was released from the agarose by incubating the plug in 3 ml of culture media for
30 minutes, with frequent pipetting up and down. The resulting virus suspension was
divided into 3 equal aliquots, and inoculated into each of 3 100 mm culture plates of HFF
monolayers. After virus adsorption at 37° C for 2 hs, the inoculum was removed from 2 of
the plates, and they were overlayed with fresh culture media until 100% CPE occurred. At
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that time, the cells were harvested for I) the generation of a high-titer stock, and 2)
infected ceil DNA isolation for Southern blot analysis. When individual plaques became
visible in the remaining plate, it was overlayed with MEM containing 10% heat-inactivated
fetal calf serum, 0.5% agarose, and X-glu, and incubated at 37° C to verify the absence of
blue plaque phenotype virus contamination during the selection of the white plaque
phenotype virus.
PCR protocols. PCR reactions in this study were performed using Platinum Taq
DNA Polymerase (Gibco BRL, Baltimore, MD), following the manufacturer’s
suggestions. The reactions were conducted in an Ericomp Delta Cycler II System (San
Diego, CA). The PCR products were analyzed by electrophoresis in 1.2 % agarose or
5 % polyacrylamide gels, and visualized by staining with ethidium bromide. The gels were
photographed with a Polaroid camera (Fotodyne Incorporated). The images presented in
chapter IV were generated with a UMAX PowerLook U Scanner with Paintshop Pro
version 5.0 Jacs Software.
Transient transfection assays. CAT reporter constructs were used to study the
expression of operator-containing US9 promoters in the presence of either HCMV
immediate-early proteins IE1 and IE2, using plasmid pSVH (Depto and Stenberg, 1989),
or wild type virus (AD 169) or recombinant virus expressing the lac repressor (RV/ac). A
DEAE-Dextran transfection protocol was performed as previously described (Stenberg et
al., 1990). To carry out the aims mentioned above, the general protocol that was
conducted was as follows. Plasmid DNA was added to a microfuge tube. 1 ml of sterile
Tris buffered saline (30 mM Tris-HCl pH 7.5, 150 mM NaCl) (TBS) was added, and the
DNA solution was mixed by vortexing. 0.5 mg DEAE-Dextran (Pharmacia, Uppsala,
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Sweden) were then added. This DNA solution was added to HFF cells on 100 mm culture
plates, which had been previously washed with TBS. The cells were incubated at 37° C for
30 minutes, with frequent rocking. This was followed by the addition of 10 ml o f lOOuM
chloroquine (Sigma, St. Louis, MO) in culture media. After the addition of chloroquine,
the cells were incubated at 37° C for 3 hs. At that time, the media was replaced with fresh
culture media, and the transfected cells were incubated at 37° C.
To study IE1 and IE2 activation of operator-containing US9 promoters, 5 ug of
pUS9opCAT, pUS9op(-l6)CAT or pUS9op(-6)CAT (or pUS9CAT as control) were
cotransfected with 5 ug o f pSVH into HFF cells. Cells were harvested 48 hs post
transfection and assayed for CAT activity. Plasmids pUS9op(-16)CAT and
pUS9op(-6)CAT were also tested for activation by AD 169 virus. 10 ug of the reporter
plasmid were transfected into HFF cells. 24 hs after transfection, the cells were infected
with 2 PFU per cell of AD 169 virus. After 2 hs adsorption at 37° C, the virus inoculum
was removed and fresh media was added. Cells were harvested 72 hs post infection and
assayed for CAT activity.
To assess lac repressor mediated repression of operator-containing promoters
(RSV promoters in pOpl3CAT and pOpRSVICAT, or US9 promoters in pUS9opCAT,
pUS9op(-l6)CAT and pUS9op(-6)CAT), 10 ug of either plasmid was transfected into
HFF cells. 24 hs after transfection, the cells were mock infected, or infected with 2 PFU
per cell of AD169 (as control), or RV/ac. After adsorption at 37° C for 2 hs, the inoculum
was removed and fresh media was added onto the infected cells. For IPTG derepression
experiments, IPTG (Fisher Scientific, Pittsburg, PA) was added after virus adsorption to
final concentrations of 0, 0.2,0.4, 0.8, or 2 mM. The cells were exposed to IPTG-
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containing media until the indicated times of harvest. Cells were harvested at 24, 48, and
72 hs post infection, and assayed for CAT activity.
In order to assess expression of the lac repressor, COS-1 cells were transfected
with 10 ug of pMIEP/ac / using the general transfection protocol described above. 48 hs
after transfection, cell extracts were prepared for western blot analysis.
Chloramphenicol acetvl transferase (CAT) assay. CAT activity was determined as
previously described (Depto and Stenberg, 1989). Transiently transfected cells were
washed with cold Tris buffered saline (TBS) twice. Using 1 ml of TBS, cells were scraped
into microfuge tubes, pelleted by centrifugation, and subsequently resuspended in 100 ul
of 0.25 M Tris-HCl pH 7.8. Three cycles of freeze-thaw were done, and the cell extracts
were centrifuged to spin out cell debris. The supernatants were transferred to new
microfuge tubes, and heat inactivated at 68° C for 10 minutes. For the acetylation reaction,
20 ul of the heat-inactivated extract was added to a reaction mix containing 0.1 uCi l4CChloramphenicol (Amersham, Chicago, IL), 70 ul of 0.25 M Tris-HCl pH 7.8, 34 ul of
sterile distilled water, and 20 ul acetyl CoA [4 mM] (Boehringer Mannheim, Indianapolis,
IN). The reaction was incubated at 37° C for 30 minutes. To stop the reaction, 750 ul of
ethyl acetate were added, immediately followed by vortexing and centrifugation of the
sample for 1 minute. The top aqueous phase was recovered and dried down. The residue
was resuspended in 20 ul of ethyl acetate, and spotted onto a thin layer chromatography
(TLC) plate (E. Merck, Darmstadt, Germany). Separation of the reaction products was
achieved by partition chromatography in a chamber containing 190 ml chloroform and
10 ml methanol, for 1 h. The TLC plate was exposed to X-Ray film (Fuji) with an
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intensifying screen at -80° C overnight. Percent acetyiation was quantitated on the TLC
plate by phosphorimager analysis (Molecular Dynamics, Sunnyvale, CA).
Southern blot analysis. The Southern blot protocol was performed as described by
Maniatis et al. (1987). 2.S ug of ///wi/III-digested, infected cell DNA was loaded onto a
0.8% agarose gel, and subjected to electrophoresis at 22 volts overnight. The gel was then
stained with ethidium bromide for 45 minutes, and subsequently photographed.
Depurination was done by submerging the gel in 0.25 M HC1 at room temperature for 10
minutes, followed by denaturation in 0.5 M NaOH, 1.5 M NaCl, at room temperature for
45 minutes. The gel was then soaked in a neutralizing solution (1 M Tris-HCl pH 8.0, 1.5
M NaCl) at room temperature for 45 minutes. After that, the DNA was transferred from
the gel onto a positively-charged nylon membrane (Pall Biodyne, Pall Biosupport, East
Hills, NY) in 10X SSC (1.5 M NaCl, 150 mM sodium citrate pH 7.0) overnight. The
following day, the DNA in the blot was UV cross-linked to the membrane (150 J), and
baked at 80° C for 1 h. Hybridization was conducted using the Boehringer Mannheim
Genius System. The DNA probes used were the 5.2 kb AD 169 HindiII X fragment, which
spans the US7 through US11 region of the HCMV genome, and a lac /-specific probe,
which was derived by digesting pMIEP/ac / with &/II and Hindlll, to render a 1.6 kb
fragment containing the lac i gene. The probes were generated with Klenow DNA
Polymerase by random primed incorporation of digoxigenin (DIG)-labeled deoxyuridinetriphosphate. The blots were exposed to the hybridization solution (containing 7 ng/ml of
DIG-labeled DNA probe), at 42° C overnight in a Micro Hybridization Incubator, Model
2000 (Robbins Scientific, Sunnyvale, CA). Southern blots were washed 3 times in 2X
SSC, 0.1% SDS at room temperature. This was followed by 3 washes in 0.5X SSC, 0.1%
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SDS at 65° C. Detection of the hybridized DNA fragments was done using an antibodyconjugate [anti-digoxigenin alkaline phosphatase conjugate (anti-DIG-AP)], and a
chemiluminescent substrate for alkaline phosphatase (Disodium 3-(4-methoxyspiro[l,2dioxetane-3,2 ’-( 5’-chloro)tricyclo [3.3.13,7]decan)-4-yl)phenylphosphate) (CSPD, Tropix,
Inc. Bedford, MA).The blots were immediately exposed to X-Ray film (Fuji) with an
intensifying screen at room temperature. The images presented in chapter IV were
generated with a UMAX PowerLook II Scanner with Paintshop Pro version 5.0 Jacs
Software.
Northern blot analysis. HFF cells in 100 mm culture plates were mock infected, or
infected with wild type AD 169, parental RV134, or recombinant viruses at an MOI of
2 PFU per cell. Virus was allowed to adsorb at 37° C for 2 hs. The inoculum was then
removed, and fresh culture media was added. Infected cells were harvested 24,48, and
72 hs post infection, and total RNA was isolated. Northern blot analysis was conducted
following the protocol described by Maniatis et ai. (1987), with modifications. One tenth
of the total RNA recovered was loaded onto a I % agarose gel containing
6.6 % formaldehyde. The RNA was subjected to electrophoresis at 70 volts for 4 hs. After
electrophoresis, the gel was photographed, and subsequently washed 3 times with sterile
distilled water. The RNA was then transferred to a Magna charge nylon membrane
(Osmonics Inc. Westborough, MA) in 10X SSC, overnight. The following day, the RNA
was fixed to the membrane by UV cross-linking (150 J), and baking at 80° C for 2 hs. The
membrane was hybridized at 42° C overnight, to 107cpm of a radiolabeled DNA probe to
the US9 gene [a HindlU-EcoRl fragment of 1578 nucleotides derived from pRV3. This
fragment comprises the US8 and US9 open reading frames (see Figure 3)]. The
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[a32P]dCTP-labeled probe was generated using the Boehringer Mannheim Random
Primed DNA labeling kit (specific activity 2 x 109cpm/ug). Following hybridization, the
blot was subjected to 2 washes in 2X SSC, 0.1% SDS, at room temperature, followed by
2-3 washes in 0. IX SSC, 0.1% SDS at 50° C. The blot was exposed to X-Ray film (Fuji)
with an intensifying screen, at -80° C overnight. The RNA in the blot was quantitated by
phosphorimager analysis (Molecular Dynamics, Sunnyvale, CA), and was expressed in
arbitrary units. To correct the data for multiplicities of infection, the blot was stripped by
boiling in 0.1% SDS for 10 minutes. The RNA in the blot was hybridized to a radiolabeled
DNA probe to the UL99 (pp28) gene. This probe was derived from plasmid p28Sl
(Depto, 1991) as a 1 kb Smal fragment from Xbal-C, comprising the entire pp28 gene
sequences. Radiolabeling of the pp28 probe, hybridization, washes, autoradiography, and
quantitation were performed as described for the US9 probe.
Western blot analysis. Western blot analysis was conducted to assess lac repressor
protein expression a) in cells transfected with pMIEP/ac /, b) in cells infected with primary
stocks of putative recombinant virus, to identify those containing lac /-positive
recombinant viruses, and c) in cells infected with purified lac /-positive recombinant
viruses. Protein expression was determined at 24,48, and 72 hs post infection. The
protocol was conducted as previously described (Stenberg et al., 1989). Cells were lysed
in 30 mM Tris-HCl pH 7.5, 1% SDS, and scraped into a microfuge tube. 60 ul of the
lysate were treated with 3 ul of (3-mercaptoethanol, and loaded on a 12.5% SDSpolyacrylamide gel. Electrophoresis was performed at 8 milliamps, overnight. The proteins
in the gel were then electroblotted onto a Nitropure nitrocellulose membrane (MSI,
Westboro, MA), at 100 volts for 2 hs, at 4° C. The membrane was subsequently treated
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with a protein-blocking solution for 1 h. After that, the blot was incubated with a rabbit
anti-/ac i polyclonal serum (Stratagene, La Jolla, CA), for I h at room temperature. This
was followed by 3 washes using RIPA-5 buffer (30 mM Tris pH 7.5, 0.5M NaCl, 12 mM
deoxycholic acid, 1% NP40,0.1% SDS) at room temperature. A goat anti-rabbit
polyclonal serum conjugated with horseradish peroxidase (Sigma, St. Louis, MO) was
used as secondary antibody, and the incubation proceeded at room temperature for 1 h.
3 RIPA-5 washes were then done at room temperature. Chemiluminescent detection was
performed by ECL (Amersham Life Science, Buckinghamshire, England), which includes
luminol as the luminescent substrate for horseradish peroxidase. The blot was exposed to
X-Ray film (Fuji) at room temperature, using an intensifying screen. The images presented
in chapter IV were generated using a UMAX PowerLook II Scanner with Paintshop Pro
version 5.0 Jacs Software.
Growth curve analysis of recombinant HCMV. HFF cells were seeded onto 25 cm2
culture flasks. Cells were infected at an MOI of 2 PFU per cell, with either parental virus
RV134 or the recombinant viruses. Infections were performed in duplicate. After virus
adsorption at 37° C for 2 hs, the inoculum was removed, and fresh culture media was
added. The infected cells were incubated at 37° C. Total virus was harvested daily (day 1
through day 7 post infection), by freezing the infected cells at -80° C, followed by thawing
at 37° C. The infected cells were then scraped into the media, and the resulting virus
suspension was transferred to a 50 ml conical tube for sonication (30 seconds). Total
infectious virus was quantitated by plaque assay on HFF cells seeded on 6 well culture
dishes, using standard procedures. Titers were expressed as log io PFU/ml.
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CHAPTER IV
RESULTS
Construction and characterization of an & coli lac repressor-expressing HCMV
Cloning of the lac / gene into an HCMV expression vector
To generate a lac repressor expressing virus (RV/ac) (see specific objectives in
chapter II), the 1.6 kb lac i gene was first cloned downstream of the HCMV major
immediate-early promoter (MIEP) in the pIE72kd expression vector to generate
pMIEP/drc / (Figure 1). The MIEP has been extensively used to express various HCMV
genes (reviewed by Stenberg, 1993). Because the MIEP is a very strong promoter that is
activated by several viral and cellular transcription factors, and is expressed throughout
the course of HCMV infection, it was hypothesized that this promoter would allow for the
expression of sufficient amounts of the lac repressor protein to efficiently block
transcription from operator-containing promoters during all times after infection. Elevated
levels of protein are necessary because the lac repressor has to kinetically outcompete the
binding of transcription factors involved in the formation of an initiation-competent
transcription complex at the operator-containing promoter site. Such competition depends
on the free concentrations of the transcription factors and the repressor, as well as the
rates of complex formation with their respective DNA binding sites. Because little is
known about these parameters for different promoters and cell types, the intracellular
concentration of lac repressor should be high.
Before inserting the MIEP-/ac / gene cassette into the virus, pMIEP/ac / (see
Figure 1) was first tested for expression of the lac repressor by transfecting it into COS
cells. COS cells are an established cell line derived from African green monkey kidney
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FIG. 1. Cloning of the lac i gene into an HCMV expression vector.Thel.6 kb
lac i gene was derived from plasmid p3’SS (Lac Switch inducible mammalian
expression system, Stratagene, La Jolla, CA). The lac i gene was cloned
downstream of the HCMV Major Immediate-Early Promoter (MIEP) in place
of IE1 cDNA in pIE72kd to generate pMIEP/ac /. H. Hindlll site, S: SstH site.
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fibroblasts. These cells have been transformed by an origin-defective mutant of Simian
Virus 40 (SV40) that codes for wild type T antigen (Gluzman, 1981). These transformed
cells produce T antigen, which makes them a suitable transfection host for expression
vectors containing SV40 origin of replication. COS cells were transfected with the
expression vector pMIEP/ac /, or pMIEP/ac / and pSVH, an expression vector containing
the SV40 origin of replication and encoding IE1 and IE2 proteins. These viral
transactivators regulate MIEP expression along with cellular transcription factors (see The
Replicative Cycle in chapter I). As a negative control for lac repressor expression, COS
cells were transfected with pSVH alone. Cell extracts were prepared for western blot
analysis 48 hs after transfection. The procedure was followed as previously described
(Stenberg et al., 1989) (see Materials and Methods). A rabbit anti-/ac / polyclonal serum
was used to detect lac repressor protein in the cell extracts. The results are presented in
Figure 2. Lac repressor protein was undetectable in cells transfected with pSVH alone. On
the other hand, significant levels of expression of the lac repressor protein were observed
in cells transfected with pMIEP/ac /. Similar levels of lac repressor were observed in cells
transfected with pMIEP/ac / and pSVH, suggesting that, at least under the experimental
conditions used, expression was mostly affected by cellular transcription factors. The
molecular weight of the repressor polypeptide was 37kD as expected. These results
demonstrated that the lac i gene can be expressed from the MIEP to significant levels,
suggesting that insertion of the MIEP-/ac / gene cassette into the HCMV genome to
generate recombinant virus RV/ac would likely result in the production of elevated levels
of the lac repressor protein during the course of infection with RV/ac. However, lac
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FIG. 2. Lac repressor expression from pMIEP/ac /. COS ceils were transfected with
either 10 ug of pMIEP/ac /, or 5 ug of pMIEP/ac i and 5 ug of pSVH, or 10 ug of
pSVH alone as a negative control. 48 hs after transfection, cell extracts were prepared
for western blot analysis. A rabbit anti-lac i polyclonal serum was used for the
detection of the 37 kilodalton-/ac repressor polypeptide. The numbers indicate
molecular weight markers in kilodaltons.
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repressor protein expression would have to be measured in RV/ac-infected cells to
confirm these speculations (see corresponding section below).

Insertion of the lac i gene into the HCMV genome
The next step was to insert the lac i gene (\HEP-/ac i gene cassette) into the viral
genome. The experimental design consisted of a replacement recombination strategy to
generate a recombinant HCMV containing the lac i gene (RV/ac) in place of a selectable
marker gene. To this end, RV134, a recombinant HCMV containing the (3-glucuronidase
(3-glu) marker gene located in a nonessential region of the viral genome (between US9
and US 10 open reading frames) (Figure 4), was used as parental virus for the homologous
recombination leading to the replacement of the 3-glu gene with the MIEP-/ac / gene
cassette. Isolation of the resulting recombinant virus was achieved by screening for altered
plaque phenotype: blue plaques (parental RV134) or white plaques (recombinant virus) in
the presence of the chromogenic substrate for 3-glu: 5-bromo-4-chIoro-3-indoIyl-3-Dglucuronide (X-glu). The detailed experimental procedure was as follows. To generate
RV/ac, the MIEP-/ac / gene cassette was first inserted into a unique Hindlll site between
US9 and US10 in the recombination vector pRV3 (Figure 3). The clone in which the
orientation of the lac i gene conforms to the direction of transcription o f the neighboring
genes (right to left in the prototype HCMV genome) was isolated. This construct,
pRVMIEP/ac /, was used to insert the MIEP-/ac / gene cassette into the 3-glu locus in
RV134 by homologous recombination directed by the appropriate flanking sequences
(Figure 4). This was accomplished by cotransfecting infectious RV134 DNA and
linearized pRVMIEP/ac / into primary human foreskin fibroblasts (HFF), using a calcium
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FIG. 3. Diagram of the recombination vector pRV3 and generation of
pRVMIEP/ac /. The MIEP-/ac / gene expression unit was inserted into a unique
Hindi.n site (generated by inserting the linker sequence
5’GGGATCCGCTCTAGAGCAAGCAAGCTTGGGCC3 ’ into an Apal site)
between US9 and US10 open reading frames in pRV3. This vector contains genes
from a nonessential region of the HCMV genome (US8 through US11) that
provide the appropriate flanking sequences to allow recombination into the viral
genome. A clone in which transcription of the lac i gene proceeds in the same
direction as the neighboring genes (right to left in the prototypic HCMV genome,
as indicated by the arrow) was isolated and designated pRVMIEP/ac /.
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FIG. 4. Insertion of the lac / gene into the HCMV genome. The target region in the viral genome for
insertion of the MIEP-lac i gene cassette was the Hindlll X fragment of the ADI 69 virus strain, which
comprises open reading frames US7 through US11. This region is nonessential for viral replication in cells
in culture. RV134 is the recombinant HCMV used as parental virus for the homologous recombination
leading to insertion of the lac i gene into the viral genome. This vims contains the marker gene B glucuronidase between US9 and US 10. RV134 produces blue plaques in the presence of the substrate for
B -glu: X-glu. Homologous recombination occurs following cotransfection of RV134 DNA and a
recombination plasmid containing the MIEP-/ac / gene cassette flanked by the appropriate flanking
sequences (see Fig. 3) into HFF cells. This results in the replacement of the B-glu gene with the MIEP-/ac /
gene cassette in the US9-US10 intergenic region, leading to the generation of a recombinant vims
containing the lac i gene. This vims produces white plaques in the presence of X-glu. UL: unique long
component of the HCMV genome, US: unique short component of the HCMV genome, H: Hindfll, E:
EcoRl, arrows in the right-left direction indicate direction of transcription of the open reading frames in the
Hindlll X region, and of the MIEP-Zorc i gene expression unit.
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phosphate precipitation procedure as described in Materials and Methods. Briefly, 8 ug of
RV134 DNA and 2 ug of linearized pRVMIEP/ac / were transfected into HFF cells.
Approximately 10 days after transfection, the first signs of cytopathic effect (CPE) were
visible. When transfected cells reached 100% CPE, primary stocks of putative
recombinant virus were harvested. In this manner, four primary stocks of virus were
obtained.
In order to identify the primary stocks that contained recombinant viruses
containing the lac i gene, the stocks, containing both wild type and recombinant viruses,
were initially screened by PCR, using lac /-specific primers (see Materials and Methods).
This initial screening involved infecting HFF cells with the primary stocks and harvesting
the infected cells at 72 hs post infection. Total cell DNA was extracted, and was
subsequently amplified by PCR using forward and reverse primers specific for the lac i
gene. These primers amplify 835 nucleotides within the lac / gene. The PCR products
were subjected to electrophoresis in 1.2% agarose, and were visualized by ethidium
bromide staining. Figure 5 shows that a PCR product of the correct size (835 base pairs)
was obtained for one stock of virus (RV3MIEP£ac3 4.26.95), indicating the presence of
recombinant virus containing the lac i gene.
In order to isolate the recombinant virus, the lac /-positive primary stock
(RV3MIEP£ac3 4.26.95) was screened by altered plaque phenotype. Briefly, HFF cells
were infected with the lac /-positive stock at 10 PFU per plate. The infected cells were
overlayed with minimum essential media (MEM) containing 10% heat-inactivated fetal
calf serum and 0.5% agarose. Approximately 550 plaques were picked 2-3 weeks after
infection, placed in individual wells o f 24 well culture dishes and incubated until CPE
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FIG. 5. PCR screening for RVlac. Primary stocks resulting from the
cotransfection of RV134 DNA and pRVMIEP/ac i were screened by PCR
using lac i specific primers (Materials and Methods). HFF cells were infected
with the primary stocks. At 72 hs post infection, the infected cells were
harvested, and total cell DNA was isolated. The extracted DNA was PCR
amplified using the lac i specific primers. The PCR products were analyzed
by electrophoresis in 1.2 % agarose, and visualized by ethidium bromide
staining. The numbers on the left represent molecular weight markers (MW
lane) in kilobases. RV134 DNA was used as negative control. Plasmid p3’SS
(which contains the lac i gene) was used as positive control. Four primary
stocks (designated RV3MIEP/ac, followed by sample number and date of
harvest of the stock) were screened.
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became visible. At that time, cells were overlayed as described above, with the addition
of 75 ug per ml of X-glu. After 3 days, wells with a white or clear overlay were
considered negative for 0-glucuronidase activity. Four individual clear plaques were
isolated, and high titer virus stocks were prepared for the four isolates. These
recombinant viruses were designated RVlac 1, RVlac 2, RVlac 3, and RVlac 4.

Genetic characterization of recombinant HCMV containing the lac i gene (RVlac)
To confirm recombination of the lac i gene into the viral genome of the white
plaque phenotype viruses isolated, as well as lac i gene insertion into the appropriate
locus, RVlac DNA was analyzed by Southern blot. Total cell DNA was prepared from
RV/ac-infected HFF cells (using the four RVlac isolates), and was digested with HindUl.
The resulting DNA fragments were subjected to electrophoresis in 0.8% agarose,
transferred to a nylon membrane and hybridized to DIG-labeled probes (see Materials
and Methods). The probes used were the HCMV AD 169 HindiII-X probe (5.2 kb) (which
spans the region US7 through US11) (see Figure 4), and a lac i probe, a 1.6 kb fragment
containing the complete lac i coding sequence. Figure 6A shows that HindUl digestion of
RVlac DNA (containing the MEEP-/ac / gene HindUl cassette) resulted in the generation
of two fragments (1.8 kb and 3.4 kb) derived from the HindQl X region. This contrasts
with the single 5.2 kb fragment derived from AD 169 DNA digested with HindQl, which
hybridized to the HindlU X probe. The new banding pattern obtained with the
recombinant virus suggests the presence of at least one additional HindUl site within the
HindUl X region, suggesting that the MIEP-/ac i gene HindUl cassette was inserted in the
appropriate locus (US9-US10 intergenic region). The presence of a 2.4 kb fragment
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FIG. 6. Genetic characterization of RVlac by Southern blot analysis. To
confirm the lac i gene insertion in place of the fl-glu gene in RV134, total cell
DNA was prepared from RVlac- or AD169-infected HFF cells, and
subsequently digested with HindlU. The resulting DNA fragments were
subjected to electrophoresis in 0.8 % agarose, transferred to a nylon membrane,
and fixed. The DNA in the blot was hybridized to an AD169 HindlU X DIGlabeled probe (Materials and Methods). This S.2 kilobase (kb) probe spans the
US7 through US11 region of the AD169 genome, and was used in the Southern
blot analysis depicted in panel A. Panel B shows the results of Southern blot
analysis using a 1.6 kb lac i gene DIG-labeled probe (comprising the entire
coding sequence of the lac i gene). The numbers on the left of the blots
represent molecular weight markers (expressed in kb). AD 169 and RV134
DNAs were used as negative controls for lac i gene-specific hybridization. MW
lane in panel B: molecular weight markers.
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hybridizing to the lac i probe (shown in Figure 6B) confirms the presence of the lac i
gene in the viral genome. The results obtained using both probes were identical for the
four isolates of RV/ac.

Lac repressor expression in RV/ac-infected cells
To determine if the lac repressor protein was expressed in RV/ac-infected cells,
western blot analysis was conducted as described in Materials and Methods, using a
rabbit anti-lac i polyclonal serum. HFF cells were infected with the four RV/ac isolates at
an MOI of 2. As a negative control for lac repressor expression, cells were infected with
RV134 at an equivalent MOI. Infected cells were harvested at 24 hs after infection, and
cell extracts were prepared for western blot analysis. The results obtained (Figure 7A)
using the four RV/ac isolates indicated that these viruses are capable of expressing
significant amounts of the 37 kD lac repressor polypeptide. This figure illustrates lac
repressor expression at 24 hs post infection. In order to address expression throughout the
course of infection, an experiment was conducted in which HFF cells were infected with
RV/ac 1, and were harvested at 24, 48, and 72 hs after infection, for western blot
analysis. As negative controls, mock and RV134 infections were performed similarly.
Figure 7B shows that the repressor is expressed throughout the course of infection, with
levels increasing at 48 and 72 hs. At those times after infection, low levels of two smaller
bands were observed. These polypeptides increased at later times of infection, and likely
represent degradation products of the 37 kD repressor polypeptide. RV/ac 1 was used in
all the subsequent experiments in this study, and is referred to as RV/ac.
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FIG. 7. Expression of the lac i gene product in RV/ac-infected ceils. (A) HFF
cells were infected with four isolates of RV/ac at 2 PFU per cell. Cells were
harvested at 24 hs, and cell extracts were prepared for western blot analysis.
As a positive control, lac i gene expression in COS cells transfected with
pMIEP/ac i was included in the analysis. A RV134-infected cell extract was
used as negative control. (B) Lac i gene expression was measured in cells
infected with RV/acl at 24,48, and 72 hs post infection. Cells that were mock
infected, or infected with RV134 and harvested at the indicated times were
used as negative controls. The numbers on the right of the blots represent
molecular weight markers in kilodaltons.
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Biological function of the lac repressor expressed from RVlac
Before addressing the response of HCMV-specific, operator-containing promoters
to repression by RVlac (see specific objectives in Chapter II), the lac repressor protein
produced in RV/ac-infected cells was tested for its repression capabilities, using operatorcontaining promoters that differ in the number and relative positions of the operator
sequences (pOpl3CAT and pOpRSVICAT, shown in Figure 8A). These reporter
plasmids were obtained along with the plasmid encoding the lac i gene (p3’SS) as part of
the Lac Switch inducible mammalian expression system (Stratagene, La Jolla, CA) (see
Materials and Methods).
Briefly, 10 ug of a CAT reporter plasmid containing lac operator sequences in the
RSV promoter (either pOpl3CAT or pOpRSVICAT) (see Figure 8A) were transfected
into HFF cells using the DEAE-Dextran transfection protocol described in Materials and
Methods. At 24 hs after transfection, cells were infected with RVlac at 2 PFU per cell.
As controls, mock infection or infection with wild type virus AD 169 at an equivalent
MOI were performed. At 24,48 and 72 hs post infection, cells were harvested and
assayed for CAT activity as previously described (Depto and Stenberg, 1989) (see
Materials and Methods). Figure 8B shows that infection of transfected cells with RV/ac
resulted in a highly significant reduction in CAT activity (80% for pOpl3CAT and 100%
for pOpRSVICAT), as compared with CAT activity in cells infected with wild type virus
AD 169. It is worth noting that a more effective repression of promoter activity resulted
when the operator sequence was adjacent to the TATA box (in pOpRSVICAT). These
results suggest that sufficient amounts of functional lac repressor were present in the
infected cells to significantly repress expression of the operator-containing promoters.
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FIG. 8. (A) Schematic diagram of reporter constructs pOpl3CAT and pOpRSVICAT. Lac operatorcontaining reporter constructs pOpl3CAT and pOpRSVICAT contain the Rous sarcoma virus (RSV)Long Terminal Repeat (LTR) promoter, the lac operator sequence
5’TGTGGAATTGTGAGCGCTCACAATTCCACAGTC3’ inserted at various positions, and the
chloramphenicol acetyl transferase reporter gene (from Stratagene Lac Switch inducible mammalian
expression system). (B) Analysis of the biological function of the lac repressor produced from RV/ac. A
representative experiment is shown. HFF cells were transfected with 10 ug of pOpl3CAT or
pOpRSVICAT. At 24 hs after transfection, cells were mock infected, or infected with AD169 or RV/ac at
2 PFU per cell. Infected cells were harvested at 24, 48, and 72 hs post infection, and cell extracts were
assayed for CAT activity. Percent acetylation was quantitated by phosphorimager analysis.
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To determine if IPTG is capable of reversing the observed repression, and to
establish the optimal concentration and time of exposure to IPTG for a maximal effect, an
IPTG titration curve was performed in which CAT activity was expressed as a function of
IPTG concentration. HFF cells were transfected with 10 ug of the reporter plasmid
pOpRSVICAT (see Figure 8A), using the DEAE-Dextran transfection protocol described
in Materials and Methods. At 24 hs after transfection, cells were infected with RVlac or
AD 169, at 2 PFU per cell, and 18 hs after infection, IPTG was added to the media at 0,
10, 25, 50 and 100 uM. 7 hs after the addition of IPTG, cells were harvested and assayed
for CAT activity as described previously. The results of these experiments are shown in
Figure 9. Consistent with the experiments shown in Figure 8, repression in RV/ac
infected cells in the absence of IPTG was highly significant (6.51% acetylation) when
compared with the level of promoter activation in AD169-infected cells at all
concentrations of IPTG tested (98% acetylation, data not shown). A 4-fold increase in
CAT activity was observed in cells infected with RV/ac in the presence of 100 uM IPTG,
as compared to the activity in cells infected with RV/ac in the absence of IPTG. The level
of IPTG mediated derepression observed (about 40%), although significant, is probably
insufficient to accurately assess conditional expression of an HCMV promoter in the
context of the viral genome. Therefore, in order to obtain a more effective derepression,
higher concentrations of IPTG, as well as different experimental conditions, such as time
of exposure to IPTG, were also tested in subsequent experiments in this study (see
corresponding section below).
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FIG. 9. IPTG induction of reporter CAT activity in RV/ac-infected cells.
HFF cells were transfected with 10 ug of reporter plasmid pOpRSVICAT,
and at 24 hs after transfection, cells were infected with AD 169 (data not
shown), or RV/ac, at 2 PFU per cell. 18 hs after infection, IPTG was added
to the media at 0, 10,25, 50, and 100 uM. 7 hs after the addition of IPTG,
cells were harvested and assayed for CAT activity. Percent acetylation was
quantitated by phosphorimager analysis. In AD169-infected cells, 98%
acetylation was observed for all the IPTG concentrations tested (data not
shown). A representative experiment is shown.
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Insertion of a lac operator sequence into an HCMV nonessential gene promoter
Central to the objectives of this project was to test the conditional expression of
an HCMV promoter utilizing the lac repressor-based system. The main aim of this study
was to address all the fundamental aspects of the system using an operator-containing
HCMV promoter and RV/ac in transient assays, before assessing the feasibility of this
approach in the context of the HCMV genome. To this end, an operator-containing
HCMV promoter was constructed and characterized. The operator-containing
promoter(s) was cloned into a CAT reporter construct for analysis of expression in
transient assays (see corresponding section below). In addition, this promoters) was
inserted into the HCMV genome in the endogenous locus, with or without the lac i gene
adjacent to it, for future analysis of conditional expression in the context of the virus. The
promoter of a nonessential gene was chosen because it would be suitable to test
conditional gene expression in the context of the virus without affecting the production of
progeny virus. In other words, the lack of expression of the operator-containing promoter
in the repressed state would not affect the ability of the virus to replicate in culture. In
this way, propagation of this recombinant virus would not be dependent on IPTG.
The US9 gene was chosen as a target for insertion of a lac operator sequence into
its promoter because the US9 gene product is known to be dispensable for growth of the
virus in tissue culture (Jones and Muzithras, 1992). Thus, a recombinant virus susceptible
to conditional expression of the US9 gene offers the advantage to test a /ac-reguiated
HCMV promoter in the context of a natural infection, and to perform experiments to
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establish optimal conditions for IPTG derepression. In addition, the US9 gene is located
immediately adjacent to the site of the lac i gene insertion (see Figure 4). This permits the
insertion of the lac i gene and the operator-containing US9 promoter into the virus in a
single recombination event, and the blue-white plaque selection method can be used for
the screening of the double insertion.
Several reports have addressed the insertion of single or multiple lac operator
sequences into various target promoters (Hu and Davidson, 1987), (Rodriguez and Smith,
1990). The obvious advantage of using multiple copies of the operator sequence is that
higher levels of repression can be obtained (Rodriguez and Smith, 1990). However, it has
also been observed that this is accompanied by a reduced ability of the inducer (IPTG) to
restore promoter activity to wild type levels. Thus, the insertion of a single, 24-base lac
operator sequence (5’GAATTGTGAGCGGAT AACAATTTC 3’) was favored in this
study.
The approach for generating an operator-containing US9 promoter initially
involved the insertion of one lac operator sequence into the leader of the US9 gene at a
unique &/II site at +40 (see Figure 10). This first step allowed for a rapid and convenient
cloning of the operator sequence. An oligonucleotide containing the lac operator
sequence was inserted into the US9 leader in pUS9CAT (Figure 11) (see Materials and
Methods).
The position of the operator sequence has been shown to be critical for effective
repression mediated by the lac repressor (Rodriguez and Smith, 1990), (Hu and
Davidson, 1987). Operator positions closer to the TATA box seem to result in higher
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5'CACGTCGGGACGATATAAAGAGGC
AopCGGTGTTTCGopGCTCCC GC AC A
-16

■

-6

+1

CAGACGACGCGTCCGGGCGGCTTCC
SstU

TGCGGCCGGCCGCopGG-|CAT \ 3 '
+40

FIG. 10. Insertion of lac operator sequences into the HCMV US9 promoter.
Partial sequence of the US9 promoter-leader upstream of the CAT gene in the
reporter construct pUS9C AT. Op represents the lac operator sequence
5’GAATTGTGAGCGGATAACAATTTC3 ’, cloned into a unique SstU site at
+40 in the leader sequence to generate pUS9opCAT, or inserted by an
overlapping PCR insertional mutagenesis protocol at the positions indicated -16
and -6, to generate pUS9op(-16)CAT, and pUS9op(-6)CAT, respectively. The
TATA box and the CAP site (G at +1) are indicated in bold. The CAT reporter
plasmids containing these US9 variant promoters are represented in Fig. 11.
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FIG. 11. Schematic diagram of operator-containing plasmid constructions. A
unique HindUl site upstream of the US9 promoter (gray box) in the
recombination vector pRV3 was generated by inserting a BamHl-Xbal-HindQl
linker (restriction enzyme recognition sequences are represented in bold in the
linker sequence below) into a unique Apal site in the US9-US10 intergenic
region (5’GGGATCCGCTCTAGAGCAAGCTTGGGCC3 ’). A unique Srtll
site at +40 in the US9 leader sequence was modified with the insertion of a
HindUl site. Plasmid pUS9CAT was generated by cloning the US9 promoterleader (-269 to +41) HindIE fragment obtained from pRV3, into a unique
HindUl site upstream of the chloramphenicol acetyl transferase (CAT) gene in
pSVOCAT. Plasmid pUS9opCAT was generated by inserting the lac operator
sequence 5’GAATTGTGAGCGGATAACAATTTC3’ (op) flanked by Sstll
linkers (SopS) into a unique &/II site at +40 in the leader of the US9
promoter-leader sequence in pUS9CAT. Using an overlapping PCR
mutagenesis strategy, the lac operator sequence was inserted at -16 or -6 in the
US9 promoter using pUS9CAT as template, to generate pUS9op(-16)CAT or
pUS9op(-6)CAT, respectively. The US9 promoters containing the operator at
-16 or -6 were cloned as HindlU-SstU fragments into pRV3 to replace the wild
type promoter in pRV3, to generate the recombination vectors pRVUS9op-16
and pRVUS9op-6, respectively. The MIEP-/ac i gene expression unit was
cloned as a HindUl fragment (derived from pRVMIEP/ac i), into the unique
HindUl site in the US9-US10 intergenic region in pRVUS9op-16 and
pRVUS9op-6, to generate pRV/acUS9op-16 and pRV/ercUS9op-6,
respectively. Transcription from all the constructs in this figure proceeds from
right to left. The empty boxes represent HCMV open reading frames of the
unique short component of the viral genome US8 through US 11, the CAT
gene, the HCMV major immediate-early promoter (MIEP), and the lac i gene.
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levels of repression, both for the lac repressor-based system (Brown et al., 1987), and the
tetracycline repressor-based system (Kim et al., 1995). Therefore, strategies were
developed for the insertion o f the operator sequence at different sites in proximity to the
TATA box within the US9 promoter. These strategies were based on modifications of
PCR protocols previously described (Zhang and Moss, 1991). A DNA fragment
containing the US9 promoter-/ac operator-CAT gene was assembled from PCR products
(see Figure 12). As mentioned previously, insertion of the operator sequence in a US9
promoter-CAT construct would allow for assessing the expression of the operatorcontaining promoters in transient assays, before analyzing these variant promoters in the
context of the virus. Two PCR reactions were performed to amplify the 5’half or the
3’half of the initial US9 promoter-CAT gene DNA fragment (obtained from pUS9CAT),
utilising two different primer pairs specifically designed to target the operator sequence
between the TATA box and the CAP site. This strategy was conducted in order to insert
the operator sequence at two alternative positions in the US9 promoter [-16 or -6, relative
to the transcription start site (+1)] (see Figure 10). For each operator location, the PCR
reactions rendered two overlapping products, which were then mixed together and PCR
amplified using the 5’-most and 3’-most primers (see Figure 12). Because a lac operator
sequence was present in one of the internal primers, the resulting PCR product contained
the lac operator in the US9 promoter upstream of the CAT gene. The final PCR product
was digested with H indSl, purified by electrophoresis in 5% polyacrylamide, and ligated
back into a unique HindlU site upstream of the CAT gene in pUS9C AT, to generate
pUS9op(-16)CAT (operator at -16), and pUS9op(-6)CAT (operator at -6) (Figure 11).
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FIG. 12. Overlapping PCR mutagenesis strategy. The lac operator sequence
5’GAATTGTGAGCGGATAACAATTTC3’ was inserted between the TATA box and the CAP site in the
HCMV US9 promoter (see Fig. 10). This was done by PCR amplifying a DNA fragment containing the US9
promoter (dotted box) and the CAT gene (stripped box), using pUS9CAT as template (see Fig. 11). Two
separate PCR reactions were conducted utilizing primers a+ b, or c+ d, to generate two overlapping PCR
products (e or f, respectively) (see Materials and Methods for actual primers used), e and f were mixed and
PCR amplified using primers a+ d, to generate the final mutagenized product g (containing the lac operator
sequence). The vertical bar in primer c, and in the DNA fragments f and g, represents the lac operator. Two
alternative insertion sites were developed: -16 or -6, relative to the transcription start site.
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The presence of the lac operator sequence in these constructs was confirmed by DNA
sequencing.

Generation of recombinant viruses using the lac repressor-operator system
Insertion of the lac i gene and the lac operator- containing US9 promoter into the HCMV
genome
In order to utilise the lac repressor and the operator-containing US9 promoter to
analyse conditional expression of the US9 gene in the context of the HCMV genome, the
lac i gene and the operator-containing US9 promoter needed to be inserted into the viral
genome in a manner that resulted in 1) adequate levels of lac repressor expression, 2)
appropriate operator location, and 3) a measurable operator-repressor interaction in the
context of viral infection. The lac operator sequence and the lac i gene can be inserted
into a single recombinant HCMV, or into two recombinant HCMV that can be used in
coinfection experiments. In this study, the complete expression system (the lac i gene,
and the operator-containing US9 promoter) was inserted into a single recombinant
HCMV. Because the US9 gene is located next to the site of insertion of the MIEP-/ac i
gene cassette (see Figure 4), the introduction of both the operator-containing US9
promoter in place of the endogenous promoter, and the lac i gene could be accomplished
in a one step recombination event. Thus, the blue-white plaque phenotype screening
method could be utilized to identify HCMV recombinants with the double insertion.
Because the operator insertion may affect sequences that are relevant for promoter
expression in the context of the viral genome, [these observations have been reported
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with other promoters (Kohler et al., 1994)], a control recombinant virus in which only the
operator-containing US9 promoter was inserted upstream of the endogenous US9 gene in
RV134 was generated. Both the operator at -16 and the operator at -6 were utilized for
this purpose.
Recombinant HCMV containing an operator sequence at -16 or -6 in the US9
promoter, with or without the lac i gene (MIEP-/ac / gene cassette), were constructed by
the replacement recombination strategy described in previous sections for the generation
of RV/ac. The strategy involved the insertion of the lac i gene in place of the (5-glu gene
in the RV134 genome (see Figure 4), as well as the replacement of the endogenous US9
promoter with the operator-containing US9 promoters. The recombination plasmids used
were pRVUS9op-16 or pRVUS9op-6 (Figure 11), which were derived from pRV3 by
replacing the US9 promoter with the operator-containing promoters from
p(JS9op(-16)CAT and pUS9op(-6)CAT, and pRV/acUS9op-16 or pRV/acUS9op-6
(Figure 11), which resulted from the insertion of the M5E?-lac i gene cassette into
pRVUS9op-16 and pRVUS9op-6, respectively (see Materials and Methods).
In addition, a control recombinant virus (RVO) was generated. This virus was
constructed by recombination between RV134 DNA and the recombination vector pRV3,
which contains no operator or lac i gene insertions. The purpose for constructing this
recombinant virus was to control for the impact of the linker sequences between US9 and
US10 (see HindlU site in Figure 3) on US9 gene expression.
The recombination plasmids were linearized with Sail, and subsequently cotransfected
with RV134 DNA into HFF cells, using the calcium phosphate precipitation protocol
described. 8 ug of RV134 DNA and 1-2 ug of linearized recombination vector
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were used. When transfected cells reached 100% CPE, primary stocks of recombinant
virus were harvested.

Screening for HCMV recombinants
In order to identify primary stocks that contained recombinant viruses, the
screening was done by PCR, using lac /-specific and US9 promoter-specific primers (see
Materials and Methods). Briefly, HFF cells were infected with the primary stocks, and
infected cell lysates were obtained 72 hs. post infection for total cell DNA extraction.
Subsequently, the DNA was amplified by PCR, using forward and reverse primers
specific for the lac i gene or the US9 promoter. The PCR products were subjected to
electrophoresis in agarose or polyacrylamide gels, and visualized by staining with
ethidium bromide. Figure 13 shows the PCR products obtained using the lac /-specific
primers to screen 18 primary stocks of virus derived from the cotransfection of RV134
and pRV/acUS9op-16 or pRV/acUS9op-6. A band of 835 nucleotides could be detected
as the PCR amplification product using the DNA from cells infected with several of the
stocks, suggesting the presence of recombinant virus containing the lac / gene. Because
some degree of nonspecific DNA amplification was observed in these experiments,
Southern and western blot analyses were conducted to confirm these results (see below).
US9 promoter-specific primers were utilized to screen for operator-containing
recombinant virus in the stocks derived from the cotransfection of RV134 with
pRVUS9op-16, or pRVUS9op-6. These primers amplify 318 nucleotides within the US9
promoter. The presence of the 24 base-operator sequence resulted in the amplification of
a larger DNA fragment (342 nucleotides) relative to the wild type US9 promoter.
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FIG. 13. PCR screening for RV/acUS9op-l6 and RV7acUS9op-6. Primary
stocks resulting from the cotransfection of RV134 DNA and
pRV/acUS9op-16 or pRV/acUS9op-6 (see Fig. 11) were screened by PCR
using lac i specific primers (Materials and Methods). HFF cells were infected
with the primaiy stocks, and at 72 hs after infection, total cell DNA was
prepared from the infected cells. The DNA was PCR amplified using the lac i
specific primers. The PCR products were subjected to electrophoresis in
1.2 % agarose, and visualized by ethidium bromide staining. The numbers on
the left represent molecular weight markers (in lanes MW) in kilobases. No
DNA or RV134 DNA were used in PCR reactions as negative controls.
RVlac DNA and the recombination plasmid pRV/acUS9op-16 were used as
positive controls. 18 primary stocks were screened. The nomenclature
represents transfection experiment number, followed by sample number.
Panel C contains repeats of the PCR screening reactions for stocks 29-1 and
24-1, which served as controls.
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Figure 13. Continued
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FIG. 14. PCR screening for RVUS9op-6 (panel A) and RVUS9op-16 (panel
B). Primary stocks resulting from the cotransfection of RV134 DNA and
pRVUS9op-6 or pRVUS9op-16 (see Fig. 11) were screened by PCR using
US9 promoter specific primers (Materials and Methods). HFF cells were
infected with the primary stocks, and 72 hs after infection, cells were
harvested and total DNA was isolated. The DNA was PCR amplified using
the US9 promoter specific primers. The resulting products were analyzed by
electrophoresis in 5 % polyacrylamide or 1.2 % agarose, and visualized by
ethidium bromide staining.The numbers on the right in panel A and on the
left in panel B represent molecular weight markers in kilobases (MW lane in
panel B). No DNA or RV670 (a recombinant HCMV deleted of the US9
gene) DNA were used as negative controls. AD 169 DNA was used as
positive control for the wild type US9 promoter. In panel B, RV134 and
RV/ac DNAs were also used as positive controls for the wild type US9
promoter. The positive control for operator-containing US9 promoter 14B3
in panel B is a recombinant virus isolated from stock 21-4 (panel A) which
contains the operator sequence at -6 in the US9 promoter. The nomenclature
for the primary stocks screened includes transfection experiment number
followed by sample number. A band indicating the presence of the operator
sequence in the US9 promoter was detected for stocks 21-4 (panel A), 34-3
and 34-4 (panel B).
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Figure 14A-B shows that three stocks were identified to contain operator-containing
recombinant virus (21-4, 34-3, and 34-4), as evidenced by the presence of a smaller band
(318 nucleotides) corresponding to the parental virus present in the stock, and a larger
band (342 nucleotides) indicating the presence o f operator-containing virus. The
nomenclature of the primary stocks reflects transfection experiment number followed by
sample number. Stock 21-4 was derived from the cotransfection o f RV134 DNA with
pRVUS9op-6. Several recombinant viruses were isolated from this stock (see
corresponding section below). One of these viruses, 14B3, was used as a positive control
for the PCR screening shown in panel B. Stocks 34-3 and 34-4 resulted from
cotransfecting RV134 DNA with pRVUS9op-16.
In order to screen for the control virus constructed by cotransfecting RV134 and
pRV3 (RVO), another pair of US9 promoter-specific primers were used. These primers
(US9 1777. 5’CGATCCCTCCTCCTGATATG3\ and US9 2280: 5’
CTCGAGAGTACACTTACTGC3’) amplified 503 nucleotides upstream of the US9
open reading frame in the wild type virus AD 169, and in RVO, but the presence of the pglu gene in the parental virus RV134 resulted in the amplification of 3,000 nucleotides.
Figure 15A-B shows the PCR products obtained when screening primary stocks derived
from the cotransfection o f RV134 and pRV3. The presence of a band of about 500
nucleotides indicates the presence of recombinant virus (RVO) in stocks 34-2,28-5,35-2,
33-3, and 34-7.
To confirm the PCR results, Southern blot analysis was performed using an
AD169 H indlll X probe, in order to screen primary stocks for RVO, and for lac operatorcontaining viruses, and using a lac /-specific probe to identify lac /-positive stocks. HFF
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FIG. 15. PCR screening for RVO. Primary stocks resulting from the
cotransfection of RV134 DNA and pRV3 (see Fig. 11) were screened by
PCR using the primers described in Chapter IV. HFF cells were infected
with the primary stocks, and 72 hs after infection, cells were harvested and
total cell DNA was isolated. The DNA was subsequently PCR amplified.
The resulting PCR amplified products were analyzed by electrophoresis in
1.2 % agarose, and visualized by ethidium bromide staining. The numbers
on the left represent molecular weight markers in kilobases (MW lanes). No
DNA or RV670 DNA were used as templates for PCR reactions that served
as negative controls. AD169, RV134 and 14B3 (RVUS9op-6) DNAs were
used as positive controls. The nomenclature of the primary stocks was as
described in Figs. 13 and 14.
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cells were infected with the primary stocks. Infected cell DNA was prepared at 72 hs post
infection, subsequently digested with HindSH, subjected to electrophoresis in agarose
gels, blotted onto nylon membranes, and hybridized to DIG-labeled probes (see Materials
and Methods). Figure 16A-B shows that H indlll digestion of the DNA derived from the
primary stocks identified by PCR to contain lac operator-containing recombinant viruses
(21-4,34-3, and 34-4) (Figure 14A-B) resulted in the generation of two fragments
derived from the H indlll X region (1.8 kb and 3.4 kb), corresponding to recombinant
virus DNA as well as the 7.7 kb fragment corresponding to the H indlll X region
containing the P-glu gene in the parental virus RV134. These fragments were detected
using the HindlU X probe. For RVO, Southern blot analysis using the H indlll X probe
failed to detect the bands corresponding to recombinant virus in the primary stocks. Only
the 7.7 kb band, representing parental RV134 DNA was detected (Figure 16C). Possibly,
the amount of recombinant virus in the stocks was too low to be detected using this
technology, while these same stocks were shown to contain recombinant virus by PCR
analysis (Figure IS). On the other hand, the use of the lac i probe resulted in the detection
of one primary stock (34-6), derived from the cotransfection of RV134 DNA and the
recombination plasmid pRV/acUS9op-16, containing the lac i gene (see Figure 17A).
This contrasts with the PCR data using the lac /-specific primers, where PCR
amplification of the DNA derived from several primary stocks showed the presence of a
lac /-specific product.
In order to identify primary stocks containing lac repressor-expressing virus,
western blot analysis was conducted. HFF cells were infected with the stocks that had
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FIG. 16. Southern blot screening for RVUS9op-6 (panel A), RVUS9op-16
(panel B), and RVO (panel C). Total cell DNA was prepared from cells
infected with RV134, RV/ac, or the primary stocks previously screened by
PCR. The DNA was digested with HindQl, and was subjected to
electrophoresis in 0.8 % agarose. The DNA fragments were then transferred to
a nylon membrane, fixed, and hybridized to the AD 169 H indlll X probe
described in Materials and Methods. The numbers on the right of the blots
represent molecular weight markers in kilobases. The expected 1.8 kb and
3.4 kb fragments (which indicate the presence of recombinant vims in the
stock) were observed in stocks 21-4, 34-3, and 34-4.
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FIG. 17. Southern (panel A) and western (panel B) blot screening for
RV/drcUS9op-16. (A) Total cell DNA was prepared from cells infected with
AD169, 16A53 (RVUS9op-6, isolated from primary stock 21-4), RVO (352
3B2) (negative controls), or RVlac (positive control), or the primary stocks
previously screened by PCR. The DNA was digested with H indlll, and was
subjected to electrophoresis in 0.8 % agarose. The DNA was then
transferred to a nylon membrane, fixed, and hybridized to the lac i gene
specific, DIG-Iabeled probe described in Materials and Methods. The
numbers on the left of the blot represent molecular weight markers (MW
lane) in kilobases. A band of 2.4 kb was detected with the lac i probe for
stock 34-6, indicating the presence of recombinant virus containing the lac i
gene in the stock. (B) HFF cell extracts were prepared from uninfected cells,
or 24 hs after infection with RV134 (negative control), RWlac (positive
control), RV3MIEP/ac3 4.26.95 (see Fig. 5) (positive control), or the
primary stocks previously screened by PCR. The cell lysates were subjected
to electrophoresis in SDS-polyacrylamide, electroblotted onto a
nitrocellulose membrane, and reacted with a rabbit anti-/ac / polyclonal
serum. MW: molecular weight markers, expressed in kilodaltons on the
right of the blot. Stock 34-6 contains recombinant virus expressing the lac
repressor. The nomenclature of the primary stocks in both panels was as
described in previous figures.
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tested positive for the lac i gene by PCR analysis, and 24 hs post infection, cells were
lysed and harvested. The cell lysates were subjected to electrophoresis in SDSpolyacrylamide gels, electroblotted onto a nitrocellulose membrane, and reacted with a
rabbit anti-/ac / polyclonal serum. Figure 17B shows that one stock (34-6, which had
been identified by Southern blot analysis using the lac i probe) contains recombinant
virus expressing the lac repressor.
These procedures allowed for the identification of primary stocks of virus that
contained 1) operator-positive, lac /-negative recombinant virus (RVUS9op(-16) [stocks
34-3 and 34-4] and RVUS9op(-6) [stock 21-4]), 2) operator-positive, lac /-positive
recombinant virus (RV/acUS9op(-16) [stock 34-6]), and 3) operator-negative, lac inegative recombinant virus (RVO [stocks 34-2, 28-5, 35-2, 33-3, and 34-7]).

Isolation of HCMV recombinants
Altered plaque phenotype screening was conducted on the primary stocks
identified as described above, in order to isolate the recombinant viruses. This screening
was performed as described for the isolation of RNlac. The recombinant viruses (white
plaque phenotype viruses) isolated using these procedures were: 13 isolates of RVUS9
op-6, 6 isolates of RVUS9op-l6, and I isolate of RVO. In spite of numerous attempts to
isolate the double insertion recombinant virus RV/acUS9op-16 (more than 4,000
individual plaques were picked and screened for the presence of the virus), this virus
could not be isolated. Although several white plaques were obtained, these were found to
contain false positive recombinant viruses, as determined by Southern and western
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blot analyses of 33 isolates. These viruses likely represent deletion mutants involving the
3-glu locus as a result of abnormal recombination events. The reason(s) for failing to
isolate the double insertion recombinant virus is unknown at this point. One possible
explanation is that the presence of both the lac i gene and lac operator sequence in the
recombination vector could result in expression of the lac repressor, followed by binding
of the lac repressor produced to the operator sequence and thereby obstructing or
preventing recombination. Thus, only very rarely would appropriate homologous
recombination occur to generate the double insertion recombinant virus. The extremely
small number of viruses resulting from this rare recombination event would make the
isolation of such viruses highly unlikely.

Genetic characterization of the white plaque phenotype viruses
To verify that the white plaque phenotype viruses isolated as described in the
previous section are recombinant viruses where homologous recombination had occurred
in the US9-US10 intergenic region in the viral genome, Southern blot analysis of
recombinant virus infected cell DNAs was conducted as previously described (see
Materials and Methods). The AD169 H indlll X DIG-labeled probe (5.2 kb) (spanning the
region US7 through US 11 in the HCMV genome), was used. Figure 18A shows that
H indlll digestion of AD169 DNA resulted in the generation of a 5.2 kb fragment
hybridizing to the H indlll X probe. On the other hand, H indlll digestion of recombinant
virus DNA resulted in the generation of two fragments derived from the HindfO. X region
(1.8 kb and 3.4 kb). Hybridization to the H indis. X probe resulted in the detection of
these two bands when the DNAs of 13 isolates of RVUS9op-6 (Figure 18A), 4 isolates of
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FIG. 18. Genetic characterization of white plaque phenotype viruses. Southern
blot analysis of recombinant virus infected cell DNA was conducted, along
with AD 169- and RWlac- infected cell DNAs as controls. The probe used to
hybridize to ////w/BI-digested DNAs was the HindW. X probe described in
Materials and Methods. (A) Isolates from stock 21-4 (RVUS9op-6). (B)
Isolates from stock 34-3 (RVUS9op-16). (C) Isolate from stock 35-2 (RVO).
The numbers on the right of the blots represent molecular weight markers in
kilobases. The expected 1.8kb and 3.4 kb fragments hybridizing to the
Hindm X probe were observed for the white plaque phenotype viruses
isolated, except 15D5 and 7D1 (panel B).
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RVUS9op-16 (Figure 18B), and 1 isolate of RVO (Figure 18C) were analyzed. For
RVUS9op-16,4 of 6 isolated recombinant viruses presented the appropriate H indlll
digestion pattern (20D6,4A6, 14C3, and 13B3).

Analysis of the growth properties of recombinant viruses
To analyze the growth rate of recombinant viruses RVO, RV/uc, RVUS9op-16,
and RVUS9op-6, and to compare them with the growth of parental virus RV134, one step
growth curves were performed as described (Jones et al., 1991), (Kerry et al., 1997). In
these experiments, the objective was to determine if the insertion of the lac i gene and the
lac operator sequence has an effect on the rate of virus replication. HFF cells were
infected with the indicated viruses at a multiplicity of infection (MOI) of 2. Total virus
was harvested daily, and virus yields were determined by plaque assay on HFF cells,
using standard procedures. Figure 19 shows the results of these experiments. No
significant differences in the growth rates of the recombinant viruses relative to the
parental virus RV134 were observed. This suggests that the insertions of the lac i gene
and the lac operator sequence in the viral genome, and the phenotypes derived from these
insertions, do not affect the rate of production of virus progeny. In addition, RVO also
replicated at similar rates, which indicates that the presence of the linker sequences in the
US9-US10 intergenic region does not have an impact on virus replication. These results
have an important implication. They suggest that the components of the lac repressorbased system can be integrated into the HCMV genome for the assessment of conditional
expression of an individual viral gene, without impacting on the capacity of the virus to
produce progeny. Thus, the system is viable in the context of the viral genome. It is worth
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FIG. 19. One step growth curve analysis of recombinant viruses. HFF
cells were infected at an MOI of 2 PFU per cell, with either parental
virus RV134, or the recombinant viruses RV/ac, RVUS9op-6,
RVUS9op-16, or RVO. Total virus was harvested daily, from day I to
day 7 after infection. Infectious virus was quantitated by standard
plaque assay on HFF cells. Titers were expressed as log,0PFU/ml.
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noting, however, that these observations with the US9 promoter should not be
generalized to the study of conditional expression of all other HCMV genes, for which
the use of the lac repressor-based system has to be optimized and tested.

Analysis of expression of operator-containing US9 promoters
Of vital importance to accomplish the objectives of this project was to demonstrate
that the operator-containing US9 promoters can be efficiently repressed by the lac
repressor, and that this can be relieved by IPTG. In addition, it was critical to demonstrate
that the operator insertion has a minimal intrinsic effect on basal promoter expression, in
order to validate the use of these promoters in this study.

US9 promoter expression in pUS9opCAT
The operator-containing US9 promoter-leader in pUS9opCAT was tested for the
impact of the operator insertion on promoter expression, as well as its susceptibility to
repression and derepression. To ensure that the insertion of the operator per se did not
affect expression of the US9 promoter, transient transfection assays were conducted as
described in previous sections. Briefly, pUS9opCAT, or pUS9CAT as control, was
cotransfected with pSVH into HFF cells. The US9 promoter belongs to the early kinetics
class, and is known to be activated by IE proteins (reviewed by Stenberg, 1993), (Spector
et al., 1990). A CAT reporter construct containing the HCMV DNA polymerase promoter
(ppolCAT) was used as a control of transfection. Cells were harvested 48 hs post
transfection, and assayed for CAT activity as described in Materials and Methods. Figure
20 shows a complete abrogation of CAT activity in cells cotransfected with pUS9opCAT
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FIG. 20. US9 promoter activation by HCMV immediate-early proteins IE1
and IE2. HFF cells were cotransfected with 5 ug of pSVH (expressing HCMV
IE1 and IE2), and 5 ug of pUS9CAT (containing the wild type US9 promoter),
or 5 ug of pUS9opCAT (containing the operator sequence at +40). ppolCAT
(containing the HCMV DNA polymerase promoter) was used as control of
transfection, by cotransfecting 5 ug of ppolCAT with 5 ug of pSVH. Cells
were harvested 48 hs after transfection, and cell extracts were assayed for CAT
activity. Percent acetylation was determined by phosphorimager analysis. A
representative experiment is shown.
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and pSVH, suggesting that the operator insertion at +40 has a negative impact on
expression. Possibly, the presence of the operator sequence in the leader adversely
affected the translation of the CAT mRNA (see Discussion).
pUS9opCAT was also tested for repression by the lac repressor in a transfectionRWlac infection experiment, which also included the reporter plasmid pOpRSVTCAT for
parallel analysis. Briefly, pLJS9opCAT was transfected into HFF cells, and the
transfected cells were infected with RWlac (at an MOI of 2) at 24 hs post transfection. As
controls, mock infection or infection with wild type virus AD 169 at an equivalent MOI
were performed. Cells were harvested at 24,48, and 72 hs post infection and assayed for
CAT activity. The results of this experiment are shown in Figure 21. The data obtained
with pOpRSVICAT is in accordance with the experiment presented in Figure 8B. On the
other hand, very low levels of CAT activity were obtained from pUS9opCAT upon
infection with wild type virus AD 169, in accordance with the results obtained with IE1
and IE2 (Figure 20), supporting the conclusion that the operator insertion in p(JS9opCAT
adversely affects promoter expression. Some degree of repression was observed (about
50%) in cells infected with RWlac. Collectively, the results regarding promoter
expression in pUS9opCAT indicated that alternative sites for operator insertions needed
to be tested, in order to obtain higher levels of promoter expression in the absence of the
repressor. To this end, the US9 promoters containing the lac operator sequence at -16 and
-6 in the CAT reporter constructs pUS9op(-16)CAT and pUS9op(-6)CAT (Figure 11)
were analyzed. The results of these experiments are described in the following sections.
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FIG. 21. Repression of the US9 promoter in pUS9opCAT. HFF cells were transfected with 10 ug of
pOpRSVlCAT (control) or pUS9opCAT. 24 hs after transfection, cells were mock infected, or infected
with AD169 or RV/ac at 2 PFU per cell. Infected cells were harvested at 24,48, and 72 hs post infection,
and cell extracts were assayed for CAT activity. Percent acetylation was determined by phosphorimager
analysis. A representative experiment is shown.
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Impact of the lac operator insertion at -16 or -6 on US9 promoter expression
It was of critical importance to first determine if the operator insertion per se had
an impact on promoter expression in pUS9op(-16)CAT and pUS9op(-6)CAT. Ideally, the
operator insertion would have minimal intrinsic effect on US9 promoter activation. Thus,
such a promoter would be suitable to test conditional expression mediated by the lac
repressor-based system both in transient assays and in the context of the viral genome. To
address this question, transient transfection experiments were conducted to assess
activation of these variant promoters by HCMV IE proteins IE I and IE2. The
experiments were performed as described for pUS9opCAT, and they demonstrated that
the lac operator sequence can be inserted into an HCMV promoter without significantly
affecting its basal level of expression in transient assays. Figure 22 shows the results of
those experiments. pUS9op(-16)CAT was activated to about 70% of wild type
pUS9CAT, whereas pUS9op(-6)CAT was activated to about 20%. Thus, the operator
insertion at -16 (closer to the TATA box) affected promoter activation by IE1 and IE2 to
a lesser extent, suggesting that in this promoter the intrinsic impact of the operator
sequence was minor. As a result, promoter activation did not differ significantly from
wild type promoter activation by IE1 and IE2. However, because promoter expression in
the endogenous locus could render different results for these promoters, given the higher
level of complexity o f regulation of promoter activity in the viral genome, both constructs
were included for the generation of recombinant viruses in this study (see corresponding
section in this chapter).
To further analyze the impact of the operator insertion on promoter expression in
pUS9op(-16)CAT and pUS9op(-6)CAT, the effect of the presence of all viral proteins on
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FIG. 22. Impact of the operator insertion on US9 promoter activation by
HCMV immediate-early proteins IE1 and IE2. HIT cells were cotransfected
with 5 ug of pSVH (expressing IE1 and IE2), and 5 ug of either pUS9CAT
(wild type US9 promoter), pUS9opCAT (operator at +40), pUS9op(-16)CAT
(operator at -16), or pUS9op(-6)CAT (operator at -6). Cells were harvested
48 hs after transfection, and cell extracts were prepared for CAT activity
assay. Percent acetylation was quantitated by phosphorimager analysis. A
representative experiment is shown.
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activation of the operator-containing US9 promoters in the CAT reporter constructs was
addressed. Transfection of these constructs into HFF cells was followed by infection with
AD 169 at 2 PFU per cell, 24 hs after transfection. Cells were harvested 72 hs post
infection, and cell extracts were prepared and assayed for CAT activity. The results of
these experiments are shown in Figure 23. In the presence of whole virus, activation of
pUS9op(-16)CAT was approximately 2-fold that of the wild type promoter in pUS9CAT,
and for pUS9op(-6)CAT, the level of activation was 6-fold relative to pUS9CAT. These
data suggest that the presence of the operator sequence at positions -16 and -6 (relative to
the transcription start site) in the US9 promoter results in the disruption of sequences that
participate in the regulation of expression of the US9 promoter in the presence of all viral
proteins. The analysis of these sequences within the US9 promoter and of the
phenotype(s) associated is beyond the scope of this study.
Supporting the observations regarding IE1 and IE2-mediated activation of the
operator-containing US9 promoters, expression of the promoter in pUS9op(-l6)CAT in
the presence of AD 169 virus was affected by the operator sequence to a lesser extent.
Overall, it was concluded that the operator sequence inserted at -16 has a lesser intrinsic
effect on transient US9 promoter expression than does the operator insertion at -6. Thus,
the US9 promoter with the operator insertion at -16 was considered more suitable for the
analysis of /ac-mediated repression in transient assays.
However, a more complex level of regulation of promoter expression occurs in
the viral genome. First, viral transactivators cooperate with cellular transcription factors
to control viral promoter expression within the viral genome. Second, promoter
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FIG. 23. Impact of the operator insertion on US9 promoter activation by viral
proteins. HFF cells were transfected with 10 ug of pUS9CAT (wild type US9
promoter), pUS9op(-16)CAT (operator at -16), or pUS9op(-6)CAT (operator
at -6). 24 hs after transfection, cells were mock infected, or infected with
AD169 at 2 PFU per cell. Infected cells were harvested 24,48, and 72 hs post
infection, and cell extracts were prepared for CAT activity assay. Percent
acetylation was quantitated by phosphorimager analysis. A representative
experiment is shown.
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expression in the endogenous locus is also affected by distant cis acting elements present
in the viral genome. Thus, the activity of the operator-containing US9 promoters in the
endogenous locus could vary significantly from that observed in the CAT reporter
constructs. To address this question, both variant promoters were constructed into the
recombination vector for insertion into the virus as described in this chapter. In this way,
US9 promoter expression could be assessed in the endogenous locus to investigate the
impact of the operator insertions in the context of the viral genome (see following
section).

Impact of the lac repressor-based system on US9 gene expression in the context of the
viral genome
A key control for validating future experiments on conditional expression of the
US9 gene in the context of the viral genome was to analyse US9 mRNA levels in
RVUS9op(-16)- and RVUS9op(-6)- infected cells, to determine if the operator insertion
per se has a significant impact on US9 gene expression. In addition, L7S9 expression was
measured in RV/ac-infected cells, to control for the impact of the MIEP-/ac / gene
cassette insertion adjacent to the endogenous US9 promoter. Moreover, US9 mRNA
levels were also assessed in RVO- infected cells, in order to determine if the linker
insertion per se affects US9 promoter activity in the context of the viral genome. In order
to perform these controls, northern blot analysis was conducted on RNA isolated from lac
/-negative viruses RVUS9op(-16)-, RVUS9op(-6)- or RVO- infected HFF cells, and from
RV/ac-infected HFF cells. The results were compared to parental RV134 virus and wild
type virus AD169. Briefly, total RNA was isolated from HFF cells infected with
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2 PFU per cell of either wild type virus, parental RV134 virus, RVO, RVUS9op(-16),
RVUS9op(-6), or RVlac, at 24,48, and 72 hs post infection. RNA samples were
subjected to northern blot analysis using a radiolabeled US9 specific probe as described
in Materials and Methods. The results are presented in Figure 24.
Several observations can be made from the results obtained. First, in contrast with
previously reported observations (Jones and Muzithras, 1991), US9 mRNA levels in cells
infected with AD 169 did not differ significantly throughout the course of infection. The
highest levels were observed at 24 hs, but these were not significantly reduced at 48 and
72 hs post infection. Second, it was interesting to observe that for all the recombinant
viruses, the kinetics of US9 gene expression was altered. All the recombinant viruses
presented lower levels of US9 mRNA at 24 hs post infection. These levels increased at 48
hs, and even more at 72 hs after infection. Thus, the US9 gene was expressed with earlylate kinetics from all the recombinant viruses. Third, in addition to a change in the
kinetics of expression, the highest US9 mRNA levels measured in cells infected with
RVO, RVUS9op-16 and RVUS9op-6 (at 72 hs post infection) were approximately 2-fold
those in cells infected with wild type AD 169 virus (at 24 hs post infection), or parental
RV134 (at 72 hs post infection). For RV134 and RVlac, the highest US9 mRNA levels
achieved (at 72 hs post infection) were approximately equal to those in cells infected with
AD169 at 24 hs.
Overall, these results showed that the insertions done within and in proximity to
the US9 promoter in the endogenous locus affected promoter expression in terms of time
of expression, leading to a change in kinetics of expression of the US9 gene.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

116

30 /

Q 24 hpi
||4 8 hpi
^ 7 2 hpi

FIG. 24. Impact of the lac repressor-based system on US9 gene expression in
the context of the viral genome. Northern blot analysis was conducted on total
RNA isolated from cells infected with AD 169, RV134, RV/ac, RVO,
RVUS9op-16, or RVUS9op-6, at 2 PFU per cell, at 24,48, and 72 hs post
infection (hpi). The RNA was subjected to electrophoresis in 1 % agarose,
transferred to a nylon membrane, fixed, and hybribized to a radiolabeled US9
specific probe ( a DNA fragment comprising the entire US9 and the majority
of US8) (Materials and Methods). The RNA was quantitated by
phosphorimager analysis, and is expressed in arbitrary units. A UL99 (pp28)
specific radiolabeled probe was used to correct for multiplicities of infection.
The results presented are average of the results from two replicate
experiments.
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Furthermore, it led to a 2-fold increase in mRNA levels when the insertions were done at
-6 and -16 in the US9 promoter (in RVUS9op-16 and RVUS9op-6), and when the linker
sequences were inserted immediately upstream of the US9 promoter (in RVO). The
mechanism(s) underlying these phenotypic changes are unknown at this point. They
likely include disruption of sequences important for the regulation of promoter activation,
which in turn influence the interactions of these sequences with viral and cellular proteins
that participate in the control of US9 promoter expression. This led to a change in
kinetics, and in the levels of mRNA produced. However, the magnitude of these changes
is probably not significant in terms of the utility of the operator-containing US9
promoters in the endogenous locus for the application of the lac repressor-based system
to assess conditional viral gene expression. The implications of these results are
presented in chapter V.

RV/aomediated repression of operator-containing US9 promoter
The aim of the experiments described in this section was to assess /ac-mediated
repression of operator-containing US9 promoter expression in transient assays. In
previous sections it was hypothesized that pUS9op(-16)CAT would be a more suitable
construct to test /ac-mediated repression in transient assays, since activation of this
variant promoter in the presence of viral proteins occurs at levels comparable to those of
the wild type US9 promoter. To this end, HFF cells were transfected with 10 ug of
pUS9op(-16)CAT. At 24 hs after transfection, transfected cells were either mock
infected, or infected with wild type AD 169 or RV/ac at 2 PFU per ceil. Cells were
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harvested at 24, 48, and 72 hs post infection, and cell extracts were prepared for CAT
activity assay. The results are presented in Figure 25. RV/ac infection of cells transfected
with pUS9op(-16)CAT resulted in a 90 % reduction in CAT activity when compared with
wild type virus infection, indicating that the operator-containing US9 promoter in
pUS9op(-16)CAT can be efficiently repressed by the lac repressor. This significant level
of repression was maintained throughout the course of infection. These findings were of
vital importance for this study: an operator-containing, HCMV-specific promoter that can
be efficiently acted upon by the lac repressor produced from RV/ac demonstrates the
feasibility of this approach to study HCMV gene expression.

Derepression of operator-containing US9 promoter by IPTG
Experiments utilizing IPTG were performed in order to assess derepression of the
operator-containing US9 promoter in pUS9op(-16)CAT. Several reports on the use of the
lac repressor based system in mammalian cells have shown that the IPTG concentrations
used to achieve maximal derepression could be varied through a low dose (1-500 uM), a
medium dose (0.5-15 mM), and a high dose (5-50 mM). Toxicity has been observed at
concentrations higher than 50 mM (Figge et al., 1988). The times of exposure to IPTG,
using operator-containing promoters upstream of the CAT reporter gene (Brown et al.,
1987), (Hu and Davidson, 1987) (Figge et al., 1988), (Labow et al., 1990), or the
luciferase gene (Rodriguez and Smith, 1990), have varied in different studies, from 7-12
hs, to up to 3 days.
Initially, an experiment to test toxicity was performed by exposing HFF cells to 0,
5,10,25, and 50 mM IPTG for 72 hs. Figure 26 shows HFF monolayers that had been
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FIG. 25. Repression of the US9 promoter in pUS9op(-16)CAT. HFF cells
were transfected with 10 ug of pUS9op(-l6)CAT. At 24 hs after transfection,
cells were either mock infected, or infected with AD169 or RV/ac at 2 PFU
per cell. 24,48, and 72 hs post infection, cells were harvested, and cell extracts
were assayed for CAT activity. Percent acetylation was quantitated by
phosphorimager analysis. A representative experiment is shown.
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FIG. 26. Exposure of HFF cells to increasing concentrations of IPTG. To
test IPTG toxicity, HFF cells were exposed to 0,5,10,25, and 50 mM IPTG
for 72hs. At that time, cells were photographed using a Photo Zoom inverted
microscope (Bausch & Lomb), and a Pentax K1000 camera. The images
presented were generated with a UMAX PowerLook II Scanner with
Paintshop Pro version 5.0 Jacs Software.
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exposed to the indicated concentrations of IPTG for 72 hs. Morphology and cell viability
did not seem to be affected by exposure to IPTG. Therefore, all the concentrations tested
were considered to be nontoxic for HFF cells, thus suitable for use in the derepression
experiments.
In this study, the procedure to assess IPTG derepression involved transfecting
HFF cells with 10 ug of pUS9op(-16)CAT, and 24 hs after transfection, the cells were
infected with RV/ac at an MOI of 2. After adsorption of the virus for 2 hs, the virus
inoculum was removed, and fresh culture media containing 0, 0.2, 0.4,0.8 or 2 mM IPTG
was added. A lower medium dose range was initially tested in order to find the minimum
concentration of IPTG that was necessary and sufficient to efficiently cause derepression.
Cells were harvested 72 hs post infection, and assayed for CAT activity as previously
described (see Materials and Methods). Figure 27 shows that 0.8 mM IPTG was capable
o f derepressing pUS9op(-16)CAT expression to levels comparable to wild type levels.
This is a significant finding, since it demonstrates that the system functions efficiently to
reverse /ac-mediated repression of an HCMV promoter. Similar results were obtained
when cells were exposed to 2 mM IPTG. The data suggest that 0.8-2 mM IPTG could be
the optimal levels of inducer to utilise in the analysis of the operator-containing US9
promoter in the viral genome. However, the conditions for IPTG induction, in terms of
IPTG concentration and time of exposure to IPTG, will have to be optimized for studying
conditional expression of the US9 promoter in the context of the viral genome.
The observations in the last two sections demonstrate that /ac-mediated repression
(using a recombinant HCMV expressing the lac repressor), and IPTG derepression can be
readily achieved using an HCMV-specific promoter in transient assays. This validated
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FIG. 27. Titration of IPTG for induction of pUS9op(-l6)CAT in cells infected
with RVlac. HFF cells were transfected with 10 ug of pUS9op(-16)CAT. At
24 hs after transfection, cells were infected with either AD169 or RVlac at 2
PFU per cell. After virus adsorption for 2 hs, IPTG was added at 0,0.2,0.4,
0.8, or 2 mM. Cells were harvested 72 hs post infection, and cell extracts were
assayed for CAT activity. Percent acetylation was quantitated by
phosphorimager analysis. Results shown correspond to a representative
experiment.
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efforts to construct this system into the virus for future analysis of conditional gene
expression during the course of HCMV infection of cells in culture.
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CHAPTER V
DISCUSSION
HCMV essential genes encode protein functions that are absolutely required for
replication of the virus in cell culture. In other words, deletion or mutation of such genes
is lethal. Thus, these genes are believed to play central roles in the replicative cycle,
leading to the production of virus progeny. To date, these genes have not been directly
tested for their roles in virus replication. Hence, their essential nature remains
speculative, and it is mostly based on homologies with HSV-1 essential genes. The
unavailability of a significant number of HCMV conditional-lethal mutants, and the lack
of cell lines to complement virus null mutants, have presented an obstacle for addressing
the role of individual essential viral gene products in the context of a natural infection
(reviewed by Stenberg and Kerry, 1995). Therefore, the need for the development of new
methodologies to address gene expression in the context of the HCMV genome, as well
as for the propagation of viruses with mutations/deletions in genes likely to be essential,
is presently clear.
In this study, a conditional expression system was developed to study the
functional roles of HCMV gene products during viral replication. This approach is based
on the Escherichia coli lac repressor protein, the lac operator DNA sequence to which
the repressor binds with high affinity and sequence specificity, and the specific inducer
IPTG. By using this system, HCMV putative essential genes can be targeted for
conditional expression by constructing recombinant viruses containing lac operator
sequences in target promoters. These operator sequences within the target promoters can
be acted upon by the lac repressor produced from the same recombinant virus or a
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coinfecting recombinant HCMV. The effect of the loss of expression of the target gene
on virus replication can then be assessed.
Several questions were addressed in this study. Can the lac repressor-operator
system be inserted into the HCMV genome to study viral gene expression? Specifically,
can the lac repressor be expressed from recombinant HCMV? Will the lac repressor
produced recognize the lac operator sequence in an HCMV promoter, in a CAT reporter
construct to first test the system in transient expression assays, as well as in the
endogenous locus in the viral genome? Will this interaction block promoter activation?
What levels of repression and IPTG-mediated derepression can be achieved? These
objectives were successfully accomplished by generating a lac repressor expressing
recombinant HCMV and a lac operator-containing, HCMV-specific promoter, and
analyzing the lac operator-repressor-IPTG interactions in the context of such a promoter.
The approaches used and the relevant findings in this study are discussed in this chapter.

The lac repressor-operator system has been shown to regulate the expression of
transfected and integrated reporter genes in mammalian cells (Brown et al., 1987), (Hu
and Davidson, 1987), (Deuschle et al., 1989), (Figge et al., 1988), as well as in
recombinant vaccinia virus-infected cells (Rodriguez and Smith, 1990 and 1990), (Fuerst
et al., 1989), (Zhang and Moss, 1991). As a novel transcriptional regulatory system in
mammalian cells, the lac repressor-operator interaction offers significant advantages for
use as a conditional genetic switch. Firstly, the use of these prokaryotic elements, which
are inert to the physiology of the eukaryotic cell, can potentially be applied for the
stringent regulation of expression of any chosen HCMV gene. In this manner, the target
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gene, and therefore viral replication, can be externally controlled. Secondly, the
repressor-operator interaction is highly specific. The lac operator sequence is present
extremely infrequently in the genomes of mammalian cells. Therefore, only the gene
under study is susceptible to regulation by the lac repressor. This strikingly contrasts with
other gene expression systems, like induction mediated by hormones, heavy metals, or
heat shock, where the inducers can affect the expression of several genes simultaneously.
Thirdly, the system can be allosterically regulated by IPTG, allowing for the reversion of
the repressed phenotype. This is an important aspect for the application of the system in
this study, due to the absolute requirement of IPTG for the propagation of recombinant
viruses with repressible promoters of essential viral genes.
For use in an eukaryotic environment, the gene encoding the lac repressor {lac i
gene) contained a modified initiation codon (GTG to ATG) for efficient translation in an
eukaryotic cell. Also, the gene was modified to include the SV40 T antigen nuclear
localization signal, in order for the protein product to localize to the nucleus. Transport
into the nucleus was thought to be of critical importance if the repressor was to be used to
regulate transcription of HCMV genes, which occurs in the nucleus and depends on the
cellular RNA polymerase n. However, in one of the earliest reports using the lac
repressor in mammalian cells, Hu and Davidson (1987) showed that expressing a lac
repressor lacking a nuclear localization signal resulted in 10% of the total repressor
localized to the nucleus, and 90% to the cytoplasm. Although the majority of the
repressor molecules were present in the cytoplasm, those present in the nucleus were
biologically active and repressed operator-containing promoters by 90%. Nonetheless, in
this study, the presence of a nuclear localization signal was considered to be important;
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since larger amounts of the repressor protein will be localized in the nucleus, lower levels
of expression of the protein will be needed to effect regulation.
The initial goal was to construct a recombinant HCMV that expresses the lac
repressor from the HCMV major immediate-early promoter (M1EP) (RV/ac) (Specific
objective 1). This recombinant virus would allow for the assessment of lac repressor
protein expression in the infected cells throughout the course of infection. In addition,
RV/ac could be used to test operator-containing HCMV promoters in transient assays.
These assays would determine the most appropriate number and relative position of the
operator sequences for effective /ac-mediated repression, to validate the insertion of such
promoters into the virus for analysis in the context of the viral genome. The MSEP-lac i
gene expression unit was inserted between open reading frames US9 and US 10, a
transcriptionally barren region in the HCMV genome. Expression driven by the MIEP
allowed for the lac repressor to be produced immediately afrer infection, and throughout
the course of viral replication. As presented in Figure 7, significant levels of the 37 kD
repressor polypeptide were observed at 24,48, and 72 hs post infection. A priori, the
amounts of the repressor polypeptide present in the RV/ac-infected cells were presumed
to be sufficient to form enough repressor tetramers to efficiently block transcription from
operator-containing promoters, although there were no previous data to support that
assumption. The fact that significant levels of the repressor were observed during the
complete replicative cycle has an important implication: expression of the lac repressor
gene under the control of the MTF.P would allow for the repressor to be available in the
RV/ac-infected cell for the regulation of expression o f operator-containing HCMV
promoters of all kinetic classes in the context of the viral genome.

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

128

The next question addressed in this study was to determine if the lac repressor
produced in RV/ac-infected cells would recognize its cognate operator sequence, and
regulate expression from operator-containing promoters. Initially, this question was
approached by analyzing the lac repressor-operator interaction using operator-containing
heterologous promoters and RV/ac in transient assays. To this end, CAT reporter
constructs driven by lac operator-containing RSV-LTR promoters (pOpl3CAT and
pOpRSVIC AT) were used (see Figure 8A). The number and relative position of the
operator sequences were different for these two constructs. pOpl3CAT contains three
tandem operator sequences immediately downstream of the RSV promoter, while
pOpRSVIC AT contains two operator sequences, one of which is located adjacent to the
TATA box, and the other one is present downstream of the RSV promoter.
Approximately 80-100% reduction in CAT activity was observed in cells transfected with
these constructs and infected with RV/ac (Figure 8B), suggesting that 1) the repressor
polypeptide was expressed at significant levels from the MIEP-/ac / gene cassette in the
viral genome, 2) presumably formed homotetramers, prior to and/or after migrating into
the nucleus, and 3) the functional repressor was present in sufficient amounts for efficient
repression of the operator-containing promoters. From Figure 8B, it is evident that a more
effective repression of promoter activity occurred when the lac operator sequence is
positioned closer to the TATA box. In RV/ac-infected cells, CAT activity 80 to 100 times
less than that obtained in the presence of wild type virus AD 169 infection represented a
highly significant level of repression. This may, at least in part, be explained by the
presence of multiple copies of the operator sequence. Sadler et al. (1980) have reported
that the half-lives of operator-repressor complexes increase with increasing numbers of
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operators in tandem, thereby enhancing the repressor capabilities to sterically block the
binding of the RNA polymerase to the transcription start site. However, the ability of
IPTG to derepress such operator-containing promoters may be reduced.
When cells transfected with pOpRSVICAT and infected with RV/ac were
exposed to IPTG, at concentrations ranging from 10 to 100 uM for 7 hs, CAT activity
rose to levels 4 times of those of cells left untreated (Figure 9). This represents a modest
level of derepression (about 40% of the level of promoter activity in AD169-infected
cells), suggesting that the repression of this operator-containing promoter was not fully
reversible. Several factors can contribute to this phenomenon. First, reversion with IPTG
may be less easily achieved due to the presence of two operator sequences. Secondly,
because of the limited permeability of the eukaryotic plasma membrane to IPTG [in
E.coli, IPTG enters the cell using the inducible lac permease system (Kennedy, 1970)],
significant amounts of the inducer may have been difficult to obtain inside the cell at the
concentrations tested. Furthermore, the amounts of IPTG transferred from the cytoplasm
to the nucleus may have been insufficient to act upon the repressor-operator complexes
on the promoter in pOpRSVICAT. Lastly, the time of exposure to IPTG was probably
insufficient, and was reflected in the magnitude of the response. From these experiments,
it was concluded that higher concentrations of IPTG and longer times of exposure to the
inducer needed to be tested in subsequent experiments in order to obtain a more effective
derepression.
The next step represented a central goal of this project. This was to construct a lac
operator-containing HCMV promoter (Specific objective 2) in order to insert it into the
endogenous locus in the HCMV genome (Specific objectives 3,4, and 5) for future
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analysis of conditional expression in the context of a natural infection, and to test its
susceptibility to RV/ac-mediated repression and derepression by IPTG in CAT reporter
constructs in transient assays (Specific objective 6). The lac operator chosen was the 24base pair sequence 5’GAATTGTGAGCGGATAACAATTTC3\ In terms of its structure,
this operator sequence is an imperfect palindrome. Simons et al. (1984) showed that
operators containing imperfect palindromes bind the lac repressor with an 88 % shorter
half-life than perfect palindromes. This may result in a more effective derepression
mediated by IPTG. Thus, an imperfect palindromic operator sequence was chosen for this
study in order to be able to dissociate the repressor-operator complexes more easily in the
presence of IPTG. This is part of concerted efforts that needed to be made to achieve
significant levels of lac repressor-mediated repression that can be efficiently reversed by
IPTG. The 24-base pair operator sequence was inserted at different positions within the
HCMV US9 promoter (see below). The US9 gene was targeted for conditional
expression because this gene is known to be dispensable for growth of the virus in
primary human fibroblasts (HFF) in culture (Jones and Muzithras, 1992). Thus, the lack
of expression of the US9 gene in the repressed state would not affect virus replication in
HFF cells. This characteristic allows for the analysis of parameters of repression and
derepression without having virus growth dependent on IPTG. Moreover, the US9 gene is
located adjacent to the site of insertion of the MIEP-/ac / gene cassette in RV/ac.
Therefore, recombinant viruses with the double insertion of the lac i gene and the lac
operator sequence can be generated after a single recombination event. By utilizing a
virus expressing the lac repressor and containing an operator-modified US9 promoter, the
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feasibility of the lac repressor-based system to study HCMV gene expression in the
context of the viral genome can be assessed.
Initially, a single lac operator sequence was inserted at a unique &/II site in the
leader sequence of the US9 gene, forty nucleotides downstream of the transcription start
site (position +40). This approach was undertaken because it represented a quick and
convenient insertion of the lac operator sequence into the US9 promoter-leader region.
Although the majority of the reports to date have favored the insertion of operators within
promoter sequences, lac operators have also been found to be biologically functional
when positioned downstream of the promoter. Deuschle et al. (1986) observed that a lac
repressor-operator complex can be formed and block transcriptional elongation when the
operator was inserted downstream of the coliphage T5 promoter. A 90 % reduction of
promoter expression was observed.
Alternatively, a single lac operator sequence was positioned 16 or 6 nucleotides
upstream of the transcription start site in the US9 gene. The criterion was to place
operator sequences at different positions relative to the TATA box. In the US9 promoter,
the operator at -16 is 6 nucleotides downstream of the TATA box, while the one
positioned at -6 is 16 nucleotides downstream of the TATA box. It has been suggested
that the lac repressor bound to an operator immediately downstream of the TATA
element sterically impairs the binding of the RNA polymerase to the transcription start
site (Brown et al., 1987). The position of the operator has been demonstrated to be critical
for effective repression mediated by the lac repressor (Rodriguez and Smith, 1990), (Hu
and Davidson, 1987).
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Another aspect to be considered for the construction of the operator-containing
US9 promoters was the number of operator sequences that needed to be inserted into the
promoter. Reports on the use of the lac repressor-operator system in mammalian cells
consistently show that tighter repression can be obtained with numerous operators in
tandem array. This could be due to an enhanced stability of the repressor-operator
complexes as a result of increased protein-protein interactions. Operators in tandem in
specific spatial arrangements are thought to lead to the formation of intervening DNA
loops upon binding of the repressor tetramers, which increases the stability of the
interactions, leading to higher levels of repression (Besse et al., 1986), (Mossing et al.,
1986), (Kramer et al., 1987). However, these tandem operator insertions can have an
intrinsic impact on promoter expression, leading to reduced promoter activity even in the
absence of the repressor. For example, when analyzing the effect of several operator
insertions on SV40 early promoter activation relative to the parental promoter upstream
of the CAT gene, Hu and Davidson (1987) showed that 1) a single operator positioned
between the transcription start site and the TATA box decreased CAT activity by about
25%, 2) two tandem operator sequences resulted in 70% reduction in CAT activity, and
3) three operators decreased CAT activity by approximately 85%. This indicates that the
operator insertions per se resulted in decreased promoter activity. For the system to
operate efficiently, it is desired that the operator have a minimal impact on promoter
expression. This seems to be more easily achieved with single operator insertions.
In addition, the presence of several operators may result in lower levels of
reversion of repression mediated by IPTG. This was observed by Rodriguez and Smith
(1990), who studied an operator-containing late vaccinia virus promoter using the
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luciferase reporter system. When a single operator was inserted, IPTG induced luciferase
activity to approximately 90% of the control levels. In contrast, when two operators were
present, reversion was only 50%.
Taking into consideration all of the evidence presented above, and because it was
hypothesized that the operator sequence at +40 may interfere with the translation of the
US9 mRNA (see below), it was therefore concluded that a single lac operator sequence at
either -16 or -6 should be inserted into the endogenous US9 promoter for future analysis
of conditional promoter expression. However, the US9 promoter-Ieader containing the
operator sequence at +40 was included in the experiments on transient expression of
operator-containing promoters in CAT reporter constructs (see below), to compare its
expression with that of the wild type US9 promoter, as well as with that of the US9
promoters with operator sequences at -16 and -6. If the operator insertion at +40 proved
to have no intrinsic effect on expression, and if it was efficiently acted upon by the lac
repressor and IPTG, it would then be considered for insertion into the viral genome for
future analysis.
By inserting the operator-containing US9 promoters into the viral genome, and
assessing repression by the lac repressor and derepression by IPTG, the feasibility of this
conditional expression system for the study of HCMV gene function during a natural
infection of cells in culture can be evaluated. As explained at the beginning of this
chapter, a HCMV gene can be targeted for conditional expression by inserting its
promoter containing an operator into the endogenous locus by homologous
recombination, provided a screening method is available to isolate the resulting
recombinant virus. The operator-containing promoter in the endogenous locus can be

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

134

acted upon by the lac repressor produced from the same recombinant virus, or a
coinfecting recombinant HCMV. Thus, targeted gene expression and virus replication can
be assessed in the repressed state. Addition of IPTG reverses the repression, and allows
for expression of the target gene. In this study, the operator-containing US9 promoter and
the lac i gene were constructed into a recombination vector (pRV/acUS9op) for insertion
into the US9-US10 intergenic region in the HCMV genome by a one step homologous
recombination event leading to the generation of a single recombinant HCMV. Although
one pool of virus was identified to contain recombinant virus, the isolation of the virus
with the double insertion was unsuccessful. The reason(s) for failing to isolate this
recombinant virus is unknown. Possibly, the lac repressor produced from the
recombination vector pRV/acUS9op in cells transfected with parental virus RV134 and
pRV/acUS9op would bind to the operator sequence in the recombination vector. The
repressor-operator interaction could therefore interfere with homologous recombination
into the RV134 DNA, leading to aberrant or lack of recombination. Hence, appropriate
recombination becomes a very rare event, which would be reflected in an extremely small
number of the double insertion recombinant virus resulting from the transfection.
Consequently, isolation of such a recombinant virus would be very difficult to achieve.
These results suggested that future studies should address conditional expression of the
operator-containing US9 promoters in the context of the viral genome by generating one
recombinant virus containing the operator-containing US9 promoter and another
recombinant virus that expresses the lac repressor, to be used in coinfection experiments.
This approach has been successfully applied to vaccinia virus (Rodriguez and Smith,
1990). Their report included the generation of a recombinant virus expressing the
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repressor protein and a series of viruses containing operator sequence(s) at different
positions between the vaccinia virus late 4b promoter and the luciferase reporter gene.
The data from coinfection experiments demonstrated optimal inhibition of luciferase
activity which could be restored after treatment with IPTG.
Before new approaches are applied to address conditional expression of the
operator-containing US9 promoters in the viral genome, it was necessary to determine if
the operator insertions at -16 and -6 in the US9 promoter in the endogenous locus had an
impact on US9 gene expression in the absence of the repressor. In order to answer this
question (see below), recombinant viruses R.VUS9op-16 and RVUS9op-6 were
generated. These viruses contain a single operator sequence located at -16 or -6,
respectively, in the US9 promoter in the viral genome. In addition, a recombinant virus
(RVO) containing the linker sequence used to perform the insertions between US9 and
US 10 in the viral genome was generated, to control for the impact of such a sequence on
endogenous US9 promoter expression.
The analysis of the growth properties of the recombinant viruses generated
(RV/ac, RVUS9op-16, RVUS9op-6, and RVO) by one step growth curves showed that
there were no significant differences in the rate of virus replication of the recombinant
viruses relative to the parental virus RV134. This implies that the lac repressor based
system can be integrated into the HCMV genome without impacting on the production of
virus progeny.
In order to test the system in transient assays, expression of the operatorcontaining US9 promoters was assessed in CAT reporter constructs (Specific objective
6). This included the analysis of promoter activity in the presence of HCMV immediate-
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early proteins IE1 and LE2, or wild type virus AD169, to investigate the impact of the
operator insertion on basal promoter expression. To determine the viability of this system
to conditionally express an HCMV promoter, the analysis on basal operator-containing
US9 promoter activity was followed by experiments addressing RV/ac-mediated
repression and restoration of activity of the operator-containing promoters by IPTG. The
operator-containing promoter-leader sequence was tested in a CAT reporter construct
(pUS9opCAT), in the presence of HCMV immediate-early proteins EE1 and IE2. From
this experiment it was concluded that this operator location was not appropriate for the
analysis of conditional expression of this promoter, since the operator insertion per se
completely abrogated CAT activity (Figure 20). Very low levels of CAT activity were
also obtained when cells transfected with pUS9opCAT were infected with AD 169
(Figure 21). A possible explanation for these results is that, given the palindromic
structure of the operator present in the leader sequence, the formation of a hairpin
structure may have reduced the translatability of the CAT mRNA. Consequently,
additional sites of insertion for the operator needed to be tested. Thus, the operator
insertions at -16 and -6 in the US9 promoter were analyzed.
To resolve the question of whether the operator insertions at -16 and -6 were
adequate for the objectives of this project, it was critical to determine the extent to which
the operators affected promoter activation in the absence of the repressor. To answer one
aspect of this question, the operator-containing US9 promoters were cloned into a CAT
reporter plasmid and tested for activation by IE1 and IE2. Figure 22 shows that the
operator positioned at -16 (in pUS9op(-16)CAT) had the least impact on promoter
expression. Activation of this promoter was 70% that of the wild-type promoter. In
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addition, promoter expression in pUS9op(-16)CAT in the presence o f all viral proteins
(Figure 23) showed a lesser impact of the operator insertion, when compared to insertion
at -6, relative to the wild type promoter in pUS9CAT. Clearly, these results suggested
that the US9 promoter with the operator adjacent to the TATA box (at position -16) was
the most appropriate promoter for an accurate analysis of repression by the lac repressor,
due to a lesser effect on basal expression of the promoter by the operator insertion.
However, because different outcomes can be expected in terms of the intrinsic influence
of the operator at different positions relative to the TATA box when the promoter is
analyzed in the context of the HCMV genome, both operator-containing US9 promoters
were inserted into the endogenous locus to generate recombinant viruses RVUS9op-16
and RVUS9op-6, as described above.
In order to determine the impact of the operator insertion on endogenous US9
promoter expression, US9 mRNA was measured in cells infected with RVUS9op-16 and
RVUS9op-6. It was desired that basal promoter activity would not be affected
significantly by the operator insertion, in order to use these variant promoters to
conditionally express the US9 gene using the lac repressor and IPTG. The results
presented in Figure 24 demonstrate that the operator insertions at -16 and -6 in the US9
promoter do not have a major impact on endogenous promoter expression. Although a 2fold increase in US9 mRNA levels was observed in cells infected with RVUS9op-16 or
RVUS9op-6, relative to the highest levels of US9 mRNA achieved in cells infected with
AD169 or RV134, these changes do not reflect a significant influence of the operator
insertion on basal promoter expression. It is worth noting that the operator insertion at -6
may be more suitable to assess lac repressor-mediated repression, since US9 mRNA
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levels in cells infected with RVUS9op-6 were equivalent to wild type levels at 24 hs post
infection, and increased approximately 2-fold at later times. Thus, basal levels of
promoter expression were not decreased as a result of the operator insertion. On the other
hand, US9 mRNA levels in cells infected with RVUS9op-16 were lower than wild type
levels at 24 hs, so this operator insertion resulted in a reduction of basal promoter activity
at early times. These data suggest that the operator insertions in the endogenous US9
promoter, in particular, when the operator is positioned at -6 relative to the transcription
start site, may be appropriate for the application of the lac repressor-based system to
study US9 gene expression in the context of the viral genome.
Furthermore, it was interesting to observe that US9 mRNA at late times was
higher than that at early times in cells infected with any of the recombinant viruses. This
suggests that insertions within and upstream of the endogenous US9 promoter have an
impact on the kinetics of US9 gene expression. This early-late pattern of gene expression
may be of no relevance for the use of the lac repressor-based system to conditionally
express the US9 gene, but it may be the subject of future studies on the regulation of
endogenous US9 promoter expression. The decrease in US9 gene expression from
RV134 at early times was also observed by Jones et al. (1991), although they reported
that this was a slight reduction.
After analyzing the intrinsic impact of the operator insertions on basal US9
promoter expression, both in transient assays and in the context of the viral genome, it
was of critical importance to examine the ability of the lac repressor produced in KVlacinfected cells to repress the expression of the operator-containing US9 promoters, in
order to demonstrate the susceptibility of an HCMV-specific promoter to regulation by
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the lac repressor. It was reasoned that because the operator insertion in pUS9op(-16)CAT
had a lesser impact on basal promoter expression in transient assays, this reporter
construct would be more suitable for the analysis of /ac-mediated repression in transient
assays. The procedure involved transfecting cells with the CAT reporter construct and
subsequently infecting with wild type virus AD 169 or RV/ac. A highly significant
reduction in CAT activity was observed in the presence of the lac repressor, at 24,48,
and 72 hs post infection (Figure 25). The repression observed was 10-fold, which is in
agreement with reports by others (Hu and Davidson, 1987), (Deuschie et al., 1990), when
using single operator insertions. Levels of repression of 30- to 50-fold have been reported
when two operators in tandem were used (Hu and Davidson, 1987). The level of
regulation by the lac repressor obtained in mammalian cells so far is substantially lower
than that within the lac operon in E.coli. In bacteria, repression of expression can be
1000-fold (Gilbert and Muller-Hill, 1970). One possibility for this significant difference
is the DNA context in which the operator is located. The different molecular
configurations of bacterial versus eukaryotic DNA (in this particular case, the viral US9
promoter) may influence the formation and/or the stability of the operator-repressor
complex, thus affecting the magnitude of the repression achieved. Another explanation
relates to the transport of the lac repressor to the nucleus of the eukaryotic cell. It is
possible that higher levels of repression were not obtained because of insufficient
amounts of functional tetrameric repressor present in the nucleus of the RV/ac-infected
cells. Although significant levels of the 37 kD polypeptide were detected at 24,48, and
72 hs in RV/ac-infected ceils (see Figure 7), the efficiency of transport of the repressor
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from the cytoplasm to the nucleus, as well as the sufficiency of functional tetramers to act
upon the operator sequence are unknown.
In contrast with these observations are the calculations by Figge et al. (1988), who
stated that “....the concentration of repressor molecules required to achieve 99.9%
operator saturation with repressor would be 5x1 O'8 M, which corresponds to 2000
repressor tetramers per nucleus. We previously calculated that our cells (CV-1P cells)
each contain approximately 4xl04 repressor tetramers. If 10% of these are contained
within the nucleus as shown by Hu and Davidson (1987), then there is sufficient
repressor present to achieve >99.9% saturation of a single chromosomal operator site”.
However, in the paper by Figge et al., a single operator-containing SV40 hybrid
early promoter-CAT gene cassette had been stably integrated into high molecular weight
DNA. In this study, as well as in others using plasmids bearing operator-modified
promoters, the number of operator sequences within the nucleus is likely to be much
higher. Therefore, the amount of repressor required for efficient saturation of all the
operator sites within the nucleus may be substantially higher as well. Finally, although
the magnitude of the response is far lower than in bacteria, the repression obtained is
probably stringent enough to assess regulation of expression of the operator-containing
US9 promoter accurately.
To assess IPTG-mediated derepression of pUS9op(-16)CAT in RV/ac-infected
cells, concentrations of IPTG ranging from 0 to 2 mM were used, and cells were exposed
to IPTG for 70 hs following infection with RV/ac. According to the reports on IPTG
induction in mammalian cells, the conditions chosen in this study represent a medium
dose of IPTG (high doses range from 5 to 50 mM, and toxicity has been reported at
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concentrations higher than SO mM), and a maximal time of exposure (in other studies,
exposure to the inducer ranged from 7-12 hs to up to 3 days). A significant level of
derepression (about 80%) o f pUS9op(-16)CAT was achieved with 0.8 and 2 mM IPTG
(Figure 27). This degree of derepression is concordant with those obtained by others (6080%) (Hu and Davidson, 1987). Although the repressed phenotype was not fully
reversed, the results obtained may still be significant. A plateau seems to have been
reached at 0.8 mM IPTG, but testing higher concentrations of IPTG may result in 100%
reversion.
The amounts of IPTG required to obtain 80% derepression in these experiments
are about 10-20 times higher than those that result in maximum induction in E.coli (0.1
mM) (Cho et al., 198S). A possible explanation is that the amount of IPTG that actually
enters into the cytoplasm, and is subsequently transferred to the nucleus, may be
significantly less than the concentrations present in the culture media. In addition, the rate
at which IPTG binds the operator-bound repressor in the nucleus may be slower than in
E.coli, resulting in derepression with slow kinetics compared to the induction process in
bacteria.
Overall, the IPTG derepression experiments suggest that IPTG can enter the
RV/crc-infected cells, and act upon the repressed operator-containing US9 promoter to
significantly relieve the block on promoter expression, leading to activation to 80% of the
parental promoter expression levels. These conclusions strictly apply to the transient
expression system. In other words, for repressed operator-containing US9 promoters in
the viral genome, the conditions for IPTG derepression would have to be optimized.
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All the observations discussed above relate to the central objective of this project,
i.e., the analysis of /ac-mediated repression of operator-containing US9 promoters in
transient assays using CAT reporter constructs, and the ability of IPTG to reverse the
repressed phenotype. Future studies, however, will analyze the lac repressor-based
system in the context of the HCMV genome.
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CHAPTER VI
CONCLUSIONS
An Escherichia coli lac repressor-based system was developed to study HCMV
gene expression in the context of the viral genome. Two major aspects were investigated:
a lac repressor expressed from recombinant HCMV, and an operator-containing HCMV
specific promoter for which lac repressor-mediated repression and restoration of
promoter activity by IPTG can be efficiently achieved. The system was first tested in
transient expression assays, to assess the feasibility of this approach to conditionally
express a HCMV specific promoter. The repressor produced from recombinant HCMV
(RV/ac) efficiently repressed operator-containing heterologous promoters in CAT
reporter constructs in transient assays. The repression observed was reversed by IPTG.
Different operator insertion sites within the HCMV US9 promoter were tested to assess
the impact of the operator sequence on basal promoter expression, both in transient
assays (using CAT reporter constructs), and when these promoters were inserted into the
viral genome. Basal promoter expression was affected to a lesser extent in transient
assays when the operator sequence was inserted at -16. Thus, this promoter was chosen
for the analysis of lac repressor-mediated repression in transient assays. The viability of
this system to control an HCMV promoter was demonstrated when efficient repression of
the operator-containing US9 promoter was observed in the presence of RV/ac, and
repression was reversed after the addition of IPTG. Moreover, the operator insertions in
the endogenous US9 locus did not affect US9 basal promoter expression significantly.
Interestingly, the operator insertions affected the kinetics of US9 gene expression in the
context of the virus: an increase in the levels of US9 mRNA at late times post infection
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was observed. These observations provide the basis for future investigation of the US9
promoter sequences affected by the operator insertions that resulted in changes in US9
promoter expression. Overall it was concluded that the lac repressor-based system can be
applied to study HCMV gene expression. Future studies may address the conditional
expression of other HCMV promoters, adapting this system so that putative essential
HCMV genes can be targeted.
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